Rank;Sourceid;Title;Type;Issn;SJR;SJR Best Quartile;H index;Total Docs. (2010);Total Docs. (3years);Total Refs.;Total Cites (3years);Citable Docs. (3years);Cites / Doc. (2years);Ref. / Doc.;Country;Publisher;Coverage;Categories
1;19479;Annual Review of Pharmacology and Toxicology;journal;15454304, 03621642;12.86;Q1;193;17;66;2944;1677;66;20.9;173,18;United States;Annual Reviews Inc.;1965-1973, 1975-ongoing;"Pharmacology (Q1); Toxicology (Q1)"
2;21191;Pharmacological Reviews;journal;15210081, 00316997;8.749;Q1;210;23;54;9201;1039;47;21.47;400,04;United States;American Society for Pharmacology and Experimental Therapeutics;1949-ongoing;"Molecular Medicine (Q1); Pharmacology (Q1)"
3;20425;Nature Reviews Drug Discovery;journal;14741776;6.569;Q1;289;253;523;7528;5738;399;13.95;29,75;United Kingdom;Nature Publishing Group;2002-ongoing;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
4;4700152457;Nano Today;journal;17480132;5.824;Q1;119;63;115;3753;1083;84;10.84;59,57;Netherlands;Elsevier BV;2006-ongoing;"Bioengineering (Q1); Biomedical Engineering (Q1); Biotechnology (Q1); Materials Science (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Nanoscience and Nanotechnology (Q1); Pharmaceutical Science (Q1)"
5;22321;Trends in Pharmacological Sciences;journal;01656147;5.544;Q1;201;80;253;5902;2946;237;12.41;73,78;Netherlands;Elsevier BV;1979-ongoing;"Pharmacology (Q1); Toxicology (Q1)"
6;12611;Drug Resistance Updates;journal;13687646, 15322084;5.3279999999999985;Q1;100;19;45;2423;612;45;13.53;127,53;United States;Churchill Livingstone;1998-ongoing;"Cancer Research (Q1); Infectious Diseases (Q1); Oncology (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
7;19409;Advanced Drug Delivery Reviews;journal;0169409X;4.742;Q1;278;128;380;15651;5385;331;15.59;122,27;Netherlands;Elsevier BV;1987-ongoing;Pharmaceutical Science (Q1)
8;13903;Cellular and Molecular Life Sciences;journal;1420682X, 14209071;4.001;Q1;194;309;865;27930;6039;850;7.26;90,39;Switzerland;Birkhauser Verlag;1997-ongoing;"Cell Biology (Q1); Cellular and Molecular Neuroscience (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
9;21195;Pharmacology and Therapeutics;journal;01637258;3.872;Q1;180;104;285;22992;3042;281;10.04;221,08;United Kingdom;Elsevier Ltd.;1975-1977, 1979-1985, 1987-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
10;18017;Neuropsychopharmacology;journal;0893133X;3.3680000000000003;Q1;204;260;838;17476;5521;783;7.05;67,22;United Kingdom;Nature Publishing Group;1987-ongoing;"Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
11;20681;Current Opinion in Pharmacology;journal;14714892;3.365;Q1;120;113;334;5804;2424;299;7.64;51,36;Netherlands;Elsevier BV;2001-ongoing;"Drug Discovery (Q1); Pharmacology (Q1)"
12;24032;Reviews of Physiology Biochemistry and Pharmacology;book series;03034240;3.236;Q1;58;0;5;0;58;5;11.6;0,00;Germany;Springer Verlag;1974-2008, 2012-ongoing;"Biochemistry (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Physiology (Q1); Physiology (medical) (Q1)"
13;23010;Journal of Controlled Release;journal;01683659;3.225;Q1;237;486;821;16584;6243;761;7.9;34,12;Netherlands;Elsevier BV;1984-ongoing;Pharmaceutical Science (Q1)
14;12455;Molecular Therapy;journal;15250024, 15250016;3.0380000000000003;Q1;158;284;799;10616;4890;684;7.36;37,38;United States;Cell Press;2000-ongoing;"Drug Discovery (Q1); Genetics (Q1); Medicine (miscellaneous) (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
15;26371;Natural Product Reports;journal;02650568, 14604752;3.02;Q1;157;83;205;13863;1625;195;8.08;167,02;United Kingdom;Royal Society of Chemistry;1984-ongoing;"Biochemistry (Q1); Drug Discovery (Q1); Organic Chemistry (Q1)"
16;21000196010;Topics in antiviral medicine;journal;21615853;2.974;Q1;37;20;50;72;283;49;7.76;3,60;United States;International Antiviral Society;2011-ongoing;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Virology (Q1)"
17;19907;Medicinal Research Reviews;journal;01986325, 10981128;2.9610000000000003;Q1;119;26;78;4452;790;76;10.63;171,23;United States;John Wiley & Sons Inc.;1981-ongoing;"Drug Discovery (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
18;21100456838;Cell Chemical Biology;journal;24519448, 24519456;2.8310000000000004;Q1;166;176;484;6762;2346;433;5.32;38,42;United States;Elsevier Inc.;2016-ongoing;"Biochemistry (Q1); Clinical Biochemistry (Q1); Drug Discovery (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
19;18148;Pain;journal;03043959;2.688;Q1;238;384;1029;15179;5524;798;6.37;39,53;United States;Lippincott Williams & Wilkins Ltd.;1975-ongoing;"Anesthesiology and Pain Medicine (Q1); Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1)"
20;15984;Journal of Molecular Medicine;journal;09462716, 14321440;2.611;Q1;127;140;408;6288;2053;383;5.33;44,91;Germany;Springer Verlag;1976-1978, 1980-1981, 1995-ongoing;"Drug Discovery (Q1); Genetics (clinical) (Q1); Molecular Medicine (Q1)"
21;19963;Molecular Pharmacology;journal;15210111, 0026895X;2.463;Q1;186;228;978;9279;4870;946;5.19;40,70;United States;American Society for Pharmacology and Experimental Therapeutics;1965-ongoing;"Molecular Medicine (Q1); Pharmacology (Q1)"
22;19615;Antimicrobial Agents and Chemotherapy;journal;10986596, 00664804;2.458;Q1;232;865;2135;27658;10674;1987;5.29;31,97;United States;American Society for Microbiology;1963-1970, 1972-ongoing;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
23;20435;Neuropharmacology;journal;00283908;2.355;Q1;150;230;759;12869;3624;746;5.25;55,95;United Kingdom;Elsevier Ltd.;1962-ongoing;"Pharmacology (Q1); Cellular and Molecular Neuroscience (Q2)"
24;5100155080;Neurotherapeutics;journal;19337213;2.32;Q1;100;53;200;4993;1295;186;6.97;94,21;United States;Springer New York LLC;2007-ongoing;"Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
25;20626;Clinical Pharmacology and Therapeutics;journal;00099236;2.295;Q1;173;298;747;6917;4073;608;6.85;23,21;United States;Wiley-Blackwell;1960-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
26;16876;Bioconjugate Chemistry;journal;15204812, 10431802;2.273;Q1;161;290;864;11662;4619;849;5.41;40,21;United States;American Chemical Society;1990-ongoing;"Bioengineering (Q1); Biomedical Engineering (Q1); Biotechnology (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1)"
27;130126;Molecular Pharmaceutics;journal;15438384, 15438392;2.252;Q1;110;230;401;10115;2543;383;6.04;43,98;United States;American Chemical Society;2004-ongoing;"Drug Discovery (Q1); Molecular Medicine (Q1); Pharmaceutical Science (Q1)"
28;29311;Current Cancer Drug Targets;journal;15680096;2.236;Q1;85;87;204;5566;1048;191;5.47;63,98;United Arab Emirates;Bentham Science Publishers;2001-ongoing;"Cancer Research (Q1); Drug Discovery (Q1); Pharmacology (Q1)"
29;18403;Apoptosis : an international journal on programmed cell death;journal;13608185, 1573675X;2.189;Q1;102;130;395;9148;1994;387;4.73;70,37;Netherlands;Kluwer Academic Publishers;1996-ongoing;"Biochemistry (medical) (Q1); Cancer Research (Q1); Clinical Biochemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Cell Biology (Q2)"
30;22418;Journal of Antimicrobial Chemotherapy;journal;03057453, 14602091;2.161;Q1;172;427;1543;10735;6410;1178;5.41;25,14;United Kingdom;Oxford University Press;1975-ongoing;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
31;21782;Psychopharmacology;journal;00333158;2.125;Q1;181;277;1032;14816;4378;977;4.19;53,49;Germany;Springer Verlag;1959-ongoing;Pharmacology (Q1)
32;4400151524;Particle and Fibre Toxicology;journal;17438977;2.097;Q1;83;42;60;2404;401;57;6.0;57,24;United Kingdom;BioMed Central;2004-ongoing;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
33;21196;Drug Discovery Today;journal;13596446;2.028;Q1;157;142;436;8237;3077;411;6.96;58,01;Netherlands;Elsevier BV;1996-ongoing;"Drug Discovery (Q1); Pharmacology (Q1)"
34;23041;Journal of Medicinal Chemistry;journal;00222623, 15204804;2.014;Q1;240;792;2377;38219;12507;2325;5.44;48,26;United States;American Chemical Society;1963-ongoing;"Drug Discovery (Q1); Molecular Medicine (Q1)"
35;23916;Environmental Pollution;journal;02697491, 18736424;2.002;Q1;194;482;1394;21910;5670;1365;3.74;45,46;United Kingdom;Elsevier Ltd.;1970-1980, 1986-ongoing;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Pollution (Q1); Toxicology (Q1)"
36;26380;Drug and Alcohol Dependence;journal;03768716;1.976;Q1;151;259;789;11528;3252;752;3.8;44,51;Netherlands;Elsevier BV;1975-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
37;20084;British Journal of Pharmacology;journal;00071188;1.966;Q1;190;502;1459;26388;6926;1375;5.06;52,57;United States;Wiley-Blackwell;1958, 1965-ongoing;Pharmacology (Q1)
38;21332;European Journal of Pharmaceutics and Biopharmaceutics;journal;09396411;1.961;Q1;138;186;716;7150;3635;705;4.85;38,44;Netherlands;Elsevier BV;1991-ongoing;"Biotechnology (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1)"
39;24749;Addiction Biology;journal;13556215, 13691600;1.932;Q1;70;45;124;3242;596;120;4.86;72,04;United States;Wiley-Blackwell;1996-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
40;21123;Pharmaceutical Research;journal;07248741, 1573904X;1.925;Q1;191;256;797;12057;4262;754;5.19;47,10;United States;Kluwer Academic/Plenum Publishers;1984-ongoing;"Biotechnology (Q1); Molecular Medicine (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
41;22452;International Journal of Neuropsychopharmacology;journal;14611457, 14695111;1.892;Q1;93;126;301;6547;1242;279;4.33;51,96;United Kingdom;Oxford University Press;1998-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
42;20063;Biochemical Pharmacology;journal;00062952;1.889;Q1;181;427;1031;23906;5236;939;5.82;55,99;Netherlands;Elsevier BV;1958-ongoing;"Biochemistry (Q1); Pharmacology (Q1)"
43;25218;Toxicological Sciences;journal;10960929, 10966080;1.874;Q1;164;269;796;12290;4074;740;5.3;45,69;United Kingdom;Oxford University Press;1981-ongoing;Toxicology (Q1)
44;21790;Antiviral Therapy;journal;13596535;1.852;Q1;78;151;376;5527;1459;361;3.52;36,60;United Kingdom;International Medical Press;1996-ongoing;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
45;4500151409;CNS and Neurological Disorders - Drug Targets;journal;18715273;1.846;Q1;78;86;125;10049;588;107;4.44;116,85;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Medicine (miscellaneous) (Q1); Neuroscience (miscellaneous) (Q1); Pharmacology (Q1)"
46;4000148203;Handbook of Experimental Pharmacology;book series;01712004;1.826;Q1;81;87;366;8617;1489;339;4.63;99,05;Germany;Springer Verlag;2005-ongoing;"Biochemistry (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
47;23086;Journal of Pharmacology and Experimental Therapeutics;journal;15210103, 00223565;1.807;Q1;209;448;1418;16609;6339;1384;4.48;37,07;United States;American Society for Pharmacology and Experimental Therapeutics;1945-ongoing;"Molecular Medicine (Q1); Pharmacology (Q1)"
48;11900154404;PLoS Neglected Tropical Diseases;journal;19352727, 19352735;1.795;Q1;110;350;447;15673;2058;407;5.02;44,78;United States;Public Library of Science;2007-ongoing;"Infectious Diseases (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Public Health, Environmental and Occupational Health (Q1)"
49;110112;Journal of immunotherapy (Hagerstown, Md. : 1997);journal;15249557;1.784;Q1;89;100;276;4322;1091;271;3.83;43,22;United States;Lippincott Williams & Wilkins Ltd.;1994-ongoing;"Immunology (Q1); Immunology and Allergy (Q1); Pharmacology (Q1); Cancer Research (Q2)"
50;4400151701;Journal of Exposure Science and Environmental Epidemiology;journal;1559064X, 15590631;1.775;Q1;81;82;206;2503;619;191;3.48;30,52;United Kingdom;Nature Publishing Group;2006-ongoing;"Pollution (Q1); Public Health, Environmental and Occupational Health (Q1); Toxicology (Q1); Epidemiology (Q2)"
51;16088;Journal of Nanobiotechnology;journal;14773155;1.77;Q1;57;34;29;1349;213;27;5.35;39,68;United Kingdom;BioMed Central;2003-ongoing;"Applied Microbiology and Biotechnology (Q1); Bioengineering (Q1); Biomedical Engineering (Q1); Medicine (miscellaneous) (Q1); Molecular Medicine (Q1); Nanoscience and Nanotechnology (Q1); Pharmaceutical Science (Q1)"
52;4000149101;Nanomedicine: Nanotechnology, Biology, and Medicine;journal;15499634, 15499642;1.768;Q1;106;94;126;3692;873;122;6.01;39,28;Netherlands;Elsevier BV;2005-ongoing;"Bioengineering (Q1); Biomedical Engineering (Q1); Materials Science (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Molecular Medicine (Q1); Nanoscience and Nanotechnology (Q1); Pharmaceutical Science (Q1)"
53;23488;Current Medicinal Chemistry;journal;09298673;1.7;Q1;158;292;769;38300;4062;758;5.22;131,16;United Arab Emirates;Bentham Science Publishers;1994-ongoing;"Molecular Medicine (Q1); Pharmacology (Q1)"
54;20104;CNS Drug Reviews;journal;1080563X, 15273458;1.699;Q1;52;0;22;0;122;21;0.0;0,00;United States;Neva Press, Inc.;1996-2007;"Pharmacology (Q1); Neuropsychology and Physiological Psychology (Q2)"
55;15576;European Neuropsychopharmacology;journal;0924977X;1.692;Q1;100;96;326;5527;1426;320;4.51;57,57;Netherlands;Elsevier BV;1990-ongoing;"Biological Psychiatry (Q1); Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
56;20129;Cardiovascular Drug Reviews;journal;15273466, 08975957;1.673;Q1;45;0;24;0;121;21;0.0;0,00;United States;Neva Press, Inc.;1988-2007;"Cardiology and Cardiovascular Medicine (Q1); Pharmacology (Q1)"
57;22072;Current Gene Therapy;journal;15665232;1.672;Q1;65;48;126;4735;663;121;5.29;98,65;United Arab Emirates;Bentham Science Publishers;2001-ongoing;"Drug Discovery (Q1); Genetics (Q1); Molecular Medicine (Q1); Genetics (clinical) (Q2); Molecular Biology (Q2)"
58;20051;BioDrugs;journal;11738804;1.664;Q1;60;46;107;2940;530;101;5.85;63,91;United Kingdom;Adis International Ltd.;1997-ongoing;"Biotechnology (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
59;20677;Current Opinion in Drug Discovery and Development;journal;13676733;1.661;Q1;75;70;219;4845;1102;197;5.88;69,21;United Kingdom;Current Drugs Ltd.;1998-2010;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
60;21168;Pharmacogenomics Journal;journal;1470269X, 14731150;1.661;Q1;78;55;123;2361;652;118;4.97;42,93;United Kingdom;Nature Publishing Group;2001-ongoing;"Genetics (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
61;20682;Current Pharmaceutical Design;journal;13816128;1.6569999999999998;Q1;140;409;943;45111;4419;842;5.21;110,30;United Arab Emirates;Bentham Science Publishers;1995-ongoing;"Drug Discovery (Q1); Pharmacology (Q1)"
62;21237;Drug Safety;journal;01145916;1.62;Q1;115;103;286;4330;1210;236;4.9;42,04;United Kingdom;Adis International Ltd.;1990-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Toxicology (Q1)"
63;21354;Expert Opinion on Therapeutic Targets;journal;14728222;1.594;Q1;78;109;343;11083;1382;328;4.09;101,68;United Kingdom;Taylor & Francis;1997-ongoing;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
64;25222;Toxicology and Applied Pharmacology;journal;10960333, 0041008X;1.577;Q1;153;293;938;15003;4035;911;4.18;51,20;United States;Elsevier Inc.;1959-ongoing;"Pharmacology (Q1); Toxicology (Q1)"
65;22454;International Journal of Pharmaceutics;journal;03785173;1.574;Q1;190;649;1606;22432;6992;1588;4.2;34,56;Netherlands;Elsevier BV;1978-ongoing;Pharmaceutical Science (Q1)
66;24791;Alcoholism: Clinical and Experimental Research;journal;01456008, 15300277;1.568;Q1;143;254;717;13213;2696;695;3.72;52,02;United States;Wiley-Blackwell;1977-ongoing;"Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
67;20659;Critical Reviews in Therapeutic Drug Carrier Systems;journal;07434863;1.5519999999999998;Q1;69;11;39;1827;176;38;3.84;166,09;United States;Begell House;1984-ongoing;"Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1)"
68;24661;Critical Reviews in Toxicology;journal;15476898, 10408444;1.546;Q1;98;45;112;5878;580;100;5.28;130,62;United Kingdom;Taylor & Francis;1971-ongoing;Toxicology (Q1)
69;84948;Expert Opinion on Drug Delivery;journal;17425247;1.546;Q1;88;98;221;9623;1125;208;5.39;98,19;United Kingdom;Taylor & Francis;2004-ongoing;Pharmaceutical Science (Q1)
70;24649;Chemical Research in Toxicology;journal;15205010, 0893228X;1.537;Q1;144;219;699;10210;3018;659;4.79;46,62;United States;American Chemical Society;1988-ongoing;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
71;20624;Clinical Pharmacokinetics;journal;03125963;1.533;Q1;150;59;181;4333;950;168;5.5;73,44;United Kingdom;Adis International Ltd.;1976-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
72;26512;Tetrahedron;journal;00404020;1.526;Q1;209;1202;3697;60039;11893;3637;3.15;49,95;United Kingdom;Elsevier Ltd.;1957-ongoing;"Biochemistry (Q1); Drug Discovery (Q1); Organic Chemistry (Q1)"
73;21226;Drug Metabolism and Disposition;journal;00909556, 1521009X;1.508;Q1;161;293;911;9178;3921;900;4.15;31,32;United States;American Society for Pharmacology and Experimental Therapeutics;1973-ongoing;"Pharmaceutical Science (Q1); Pharmacology (Q1)"
74;144771;Clinical Trials;journal;17407753, 17407745;1.507;Q1;55;76;198;1771;415;157;2.75;23,30;United States;SAGE Publications;2004-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
75;22983;Journal of Clinical Pharmacology;journal;00912700;1.5019999999999998;Q1;106;166;407;3971;1622;382;4.32;23,92;United States;Wiley-Blackwell;1961-1964, 1970-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
76;5400152706;Nanotoxicology;journal;17435390, 17435404;1.501;Q1;72;33;78;1602;415;74;3.94;48,55;United Kingdom;Informa Healthcare;2007-ongoing;"Biomedical Engineering (Q1); Toxicology (Q1); Nanoscience and Nanotechnology (Q2)"
77;4000148019;AAPS Journal;journal;15507416;1.494;Q1;96;83;193;3723;955;182;4.19;44,86;United States;Springer New York;1999-ongoing;Pharmaceutical Science (Q1)
78;20783;Expert Review of Vaccines;journal;14760584;1.482;Q1;75;144;390;10509;1517;332;4.59;72,98;United Kingdom;Taylor & Francis;2002-ongoing;"Drug Discovery (Q1); Pharmacology (Q1); Immunology (Q2); Molecular Medicine (Q2)"
79;21169;Pharmacological Research;journal;10436618, 10961186;1.479;Q1;118;133;340;8179;1663;328;4.49;61,50;United States;Elsevier Inc.;1989-ongoing;Pharmacology (Q1)
80;7700153108;International journal of nanomedicine;journal;11782013, 11769114;1.4469999999999998;Q1;100;115;127;4368;708;124;6.4;37,98;New Zealand;Dove Medical Press Ltd;2006-ongoing;"Bioengineering (Q1); Biomaterials (Q1); Biophysics (Q1); Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Organic Chemistry (Q1); Nanoscience and Nanotechnology (Q2)"
81;25152;Journal of Toxicology and Environmental Health - Part B: Critical Reviews;journal;10937404, 15216950;1.4380000000000002;Q1;70;27;50;2257;235;44;5.59;83,59;United Kingdom;Taylor & Francis;1998-ongoing;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1)"
82;24763;Addictive Behaviors;journal;03064603;1.429;Q1;114;204;642;7569;1864;640;2.45;37,10;United Kingdom;Elsevier Ltd.;1975-ongoing;"Clinical Psychology (Q1); Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
83;23079;Journal of Pharmaceutical Sciences;journal;00223549;1.423;Q1;159;439;1027;17119;3831;980;3.7;39,00;United States;Elsevier Inc.;1961-ongoing;Pharmaceutical Science (Q1)
84;19617;Antiviral Research;journal;01663542;1.409;Q1;108;190;358;11217;1547;354;4.78;59,04;Netherlands;Elsevier BV;1959, 1981-ongoing;"Pharmacology (Q1); Virology (Q2)"
85;12331;Current Topics in Medicinal Chemistry;journal;15680266;1.399;Q1;104;143;439;13860;1611;369;4.33;96,92;United Arab Emirates;Bentham Science Publishers;2001-ongoing;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1)"
86;25075;Ecotoxicology;journal;09639292, 15733017;1.38;Q1;81;161;278;8370;890;274;3.23;51,99;Netherlands;Kluwer Academic Publishers;1992-ongoing;"Health, Toxicology and Mutagenesis (Q1); Management, Monitoring, Policy and Law (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
87;12584;Drug Metabolism Reviews;journal;10979883, 03602532;1.371;Q1;89;40;93;4582;459;88;4.6;114,55;United States;Marcel Dekker Inc.;1972-ongoing;"Pharmacology (medical) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
88;23053;Journal of Natural Products;journal;01633864, 15206025;1.37;Q1;124;403;1161;11181;3770;1116;3.11;27,74;United States;American Chemical Society;1949, 1971, 1973, 1978-ongoing;"Analytical Chemistry (Q1); Complementary and Alternative Medicine (Q1); Drug Discovery (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
89;21351;Expert Opinion on Investigational Drugs;journal;13543784;1.367;Q1;94;150;478;11809;1932;447;4.39;78,73;United Kingdom;Taylor & Francis;1994-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
90;20049;Behavioural Pharmacology;journal;14735849, 09558810;1.359;Q1;76;81;205;5428;629;203;2.97;67,01;United States;Lippincott Williams & Wilkins Ltd.;1992-ongoing;"Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
91;20664;Current Drug Targets;journal;13894501;1.356;Q1;92;160;372;17091;1272;332;3.45;106,82;United Arab Emirates;Bentham Science Publishers;2000-ongoing;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
92;29318;Anti-Cancer Agents in Medicinal Chemistry;journal;18715206, 18755992;1.354;Q1;82;87;214;7351;895;194;4.36;84,49;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Pharmacology (Q1); Cancer Research (Q2); Molecular Medicine (Q2)"
93;23109;Journal of Psychopharmacology;journal;02698811;1.351;Q1;106;231;391;9785;1319;319;3.66;42,36;United States;SAGE Publications;1987-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
94;145164;Human Genomics;journal;14739542, 14797364;1.348;Q1;49;36;49;477;114;39;2.92;13,25;United Kingdom;BioMed Central;2003-2006, 2008-ongoing;"Drug Discovery (Q1); Genetics (Q2); Molecular Biology (Q2); Molecular Medicine (Q2)"
95;4700152872;Journal of NeuroImmune Pharmacology;journal;15571890, 15571904;1.344;Q1;64;57;128;4685;441;120;3.67;82,19;Germany;Springer Verlag;2006-ongoing;"Immunology and Allergy (Q1); Pharmacology (Q1); Immunology (Q2); Neuroscience (miscellaneous) (Q2)"
96;20680;Current Opinion in Molecular Therapeutics;journal;14648431;1.336;Q1;60;88;212;5913;727;191;4.01;67,19;United Kingdom;Current Drugs Ltd.;1999-2010;"Drug Discovery (Q1); Pharmacology (Q1); Genetics (Q2); Genetics (clinical) (Q2); Molecular Biology (Q2); Molecular Medicine (Q2)"
97;24028;Reproductive Toxicology;journal;08906238;1.334;Q1;99;136;336;6145;1426;317;3.54;45,18;Netherlands;Elsevier BV;1987-ongoing;Toxicology (Q1)
98;21197;Pharmacology Biochemistry and Behavior;journal;00913057;1.32;Q1;126;228;694;12428;2174;689;2.92;54,51;United States;Elsevier Inc.;1973-ongoing;"Clinical Biochemistry (Q1); Pharmacology (Q1); Toxicology (Q1); Behavioral Neuroscience (Q2); Biochemistry (Q2); Biological Psychiatry (Q2)"
99;21767;Progress in Neuro-Psychopharmacology and Biological Psychiatry;journal;02785846;1.317;Q1;114;301;869;11901;2631;689;3.8;39,54;Netherlands;Elsevier BV;1982-ongoing;"Pharmacology (Q1); Biological Psychiatry (Q2)"
100;14144;Experimental and Clinical Psychopharmacology;journal;10641297;1.3130000000000002;Q1;82;58;157;3134;511;157;2.79;54,03;United States;American Psychological Association;1993-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
101;28792;Cancer Biology and Therapy;journal;15384047;1.31;Q1;101;359;1086;14009;2379;817;2.83;39,02;United States;Landes Bioscience;2002-ongoing;"Oncology (Q1); Pharmacology (Q1); Cancer Research (Q2); Molecular Medicine (Q2)"
102;7000153203;Journal of Studies on Alcohol and Drugs;journal;19371888, 19384114;1.3090000000000002;Q1;116;115;284;4541;795;281;2.38;39,49;United States;Center of Alcohol Studies, Rutgers, The State University of New Jersey;2007-ongoing;"Health (social science) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
103;15581;Current Pharmaceutical Biotechnology;journal;13892010;1.298;Q1;73;106;167;7390;613;151;4.12;69,72;United Arab Emirates;Bentham Science Publishers;2000-ongoing;"Biotechnology (Q1); Pharmaceutical Science (Q1)"
104;21331;European Journal of Pharmaceutical Sciences;journal;09280987;1.295;Q1;119;190;407;7133;1397;396;3.61;37,54;Netherlands;Elsevier BV;1993-ongoing;Pharmaceutical Science (Q1)
105;4400151608;ChemMedChem;journal;18607187, 18607179;1.294;Q1;92;215;584;9609;2045;568;3.44;44,69;Germany;Wiley - V C H Verlag GmbbH & Co.;2006-ongoing;"Organic Chemistry (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Molecular Medicine (Q2)"
106;19900193739;Nucleic Acid Therapeutics;journal;21593345, 21593337;1.29;Q1;61;38;107;1291;322;106;3.19;33,97;United States;Mary Ann Liebert Inc.;2011-ongoing;"Drug Discovery (Q1); Biochemistry (Q2); Genetics (Q2); Molecular Biology (Q2); Molecular Medicine (Q2)"
107;22552;Cardiovascular Drugs and Therapy;journal;15737241, 09203206;1.289;Q1;63;56;187;2365;517;148;3.53;42,23;Netherlands;Kluwer Academic Publishers;1987-ongoing;"Cardiology and Cardiovascular Medicine (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
108;21167;Pharmacogenomics;journal;14622416;1.281;Q1;83;199;520;7411;1903;436;4.26;37,24;United Kingdom;Ashley Publications Ltd.;2000-ongoing;"Pharmacology (Q1); Genetics (Q2); Molecular Medicine (Q2)"
109;14990;Current Neuropharmacology;journal;1570159X;1.271;Q1;58;43;72;4630;296;69;4.25;107,67;United Arab Emirates;Bentham Science Publishers;2004-ongoing;"Medicine (miscellaneous) (Q1); Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Neurology (Q2)"
110;22477;Investigational New Drugs;journal;01676997, 15730646;1.265;Q1;80;115;217;4059;672;214;2.85;35,30;Netherlands;Kluwer Academic Publishers;1983-ongoing;"Oncology (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
111;20679;Current Opinion in Investigational Drugs;journal;14724472;1.257;Q1;71;145;362;10224;1280;325;4.1;70,51;United Kingdom;Current Drugs Ltd.;1994, 2000-2010;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
112;13250;Expert Opinion on Biological Therapy;journal;14712598;1.256;Q1;75;149;413;12932;1474;401;3.73;86,79;United Kingdom;Taylor & Francis;2001-ongoing;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmacology (Q1)"
113;21165;PharmacoEconomics;journal;11707690;1.253;Q1;91;110;238;4458;748;189;4.27;40,53;United Kingdom;Adis International Ltd.;1992-ongoing;"Health Policy (Q1); Pharmacology (Q1); Public Health, Environmental and Occupational Health (Q1)"
114;21124;Pharmaceutical Statistics;journal;15391612, 15391604;1.25;Q1;33;33;91;559;154;83;1.56;16,94;United States;John Wiley & Sons Inc.;2004-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Statistics and Probability (Q2)"
115;20663;Current Drug Metabolism;journal;13892002;1.247;Q1;97;74;269;7949;1267;253;4.77;107,42;United Arab Emirates;Bentham Science Publishers;2000-ongoing;"Clinical Biochemistry (Q1); Pharmacology (Q1)"
116;18966;Mutagenesis;journal;02678357, 14643804;1.246;Q1;82;78;162;3437;669;154;4.4;44,06;United Kingdom;Oxford University Press;1986-ongoing;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1); Genetics (Q2); Genetics (clinical) (Q2)"
117;26514;Tetrahedron Letters;journal;00404039;1.245;Q1;159;1763;5328;59311;14398;5276;2.71;33,64;United Kingdom;Elsevier Ltd.;1959-ongoing;"Drug Discovery (Q1); Organic Chemistry (Q1); Biochemistry (Q2)"
118;25240;Toxicology Letters;journal;03784274;1.233;Q1;129;307;667;12512;2533;638;3.7;40,76;Netherlands;Elsevier BV;1977-ongoing;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
119;29097;Cancer Chemotherapy and Pharmacology;journal;03445704;1.219;Q1;100;251;741;7861;2243;714;3.1;31,32;Germany;Springer Verlag;1978-ongoing;"Oncology (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Toxicology (Q1); Cancer Research (Q2)"
120;25219;Toxicology;journal;0300483X;1.218;Q1;143;226;820;11295;3047;788;3.86;49,98;Netherlands;Elsevier BV;1959, 1973-ongoing;Toxicology (Q1)
121;20082;British Journal of Clinical Pharmacology;journal;13652125, 03065251;1.194;Q1;131;208;710;6001;2148;525;3.99;28,85;United Kingdom;Blackwell Publishing Inc.;1974-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
122;23015;Journal of Ethnopharmacology;journal;03788741;1.193;Q1;170;533;1239;19512;4410;1222;3.1;36,61;Netherlands;Elsevier BV;1979-ongoing;"Drug Discovery (Q1); Pharmacology (Q1)"
123;4700152848;PPAR Research;journal;16874757, 16874765;1.176;Q1;40;61;172;4795;460;159;2.64;78,61;Egypt;Hindawi Publishing Corporation;2006-ongoing;"Drug Discovery (Q1); Pharmacology (medical) (Q1)"
124;25109;Inhalation Toxicology;journal;08958378, 10917691;1.1740000000000002;Q1;77;141;289;6007;880;263;2.69;42,60;United Kingdom;Taylor & Francis;1989-ongoing;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1)"
125;24619;Journal of Computer-Aided Molecular Design;journal;15734951, 0920654X;1.1740000000000002;Q1;89;87;186;3791;654;178;3.27;43,57;Netherlands;Kluwer Academic Publishers;1987-ongoing;"Computer Science Applications (Q1); Drug Discovery (Q1); Physical and Theoretical Chemistry (Q1)"
126;22981;Journal of Cardiovascular Pharmacology;journal;15334023, 01602446;1.173;Q1;91;180;397;7869;1224;382;2.85;43,72;United States;Lippincott Williams & Wilkins Ltd.;1979-ongoing;"Cardiology and Cardiovascular Medicine (Q1); Pharmacology (Q1)"
127;5800173385;Recent Patents on Anti-Cancer Drug Discovery;journal;15748928;1.156;Q1;36;20;68;2718;213;68;3.19;135,90;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (medical) (Q1); Cancer Research (Q2); Oncology (Q2)"
128;23014;Journal of Drug Targeting;journal;10292330, 1061186X;1.152;Q1;80;85;228;3686;743;211;2.76;43,36;United Kingdom;Taylor & Francis;1986-1987, 1992-ongoing;Pharmaceutical Science (Q1)
129;110174;Prostaglandins and Other Lipid Mediators;journal;10988823;1.146;Q1;67;49;166;2791;467;163;2.3;56,96;Netherlands;Elsevier BV;1996, 1998-ongoing;"Pharmacology (Q1); Biochemistry (Q2); Physiology (Q2); Cell Biology (Q3)"
130;18071;Neurotoxicity Research;journal;10298428;1.13;Q1;65;75;161;3832;478;159;3.06;51,09;United States;Springer New York LLC;2001-ongoing;"Toxicology (Q1); Neuroscience (miscellaneous) (Q2)"
131;18073;NeuroToxicology;journal;0161813X;1.128;Q1;102;100;420;4813;1329;397;3.25;48,13;Netherlands;Elsevier BV;1979-ongoing;"Toxicology (Q1); Neuroscience (miscellaneous) (Q2)"
132;23061;Journal of Pharmaceutical and Biomedical Analysis;journal;07317085;1.118;Q1;114;476;1359;12899;4276;1345;3.07;27,10;Netherlands;Elsevier BV;1983-ongoing;"Analytical Chemistry (Q1); Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmaceutical Science (Q1); Spectroscopy (Q2)"
133;34645;Skin Pharmacology and Physiology;journal;16605527, 16605535;1.117;Q1;68;56;124;2143;435;111;3.43;38,27;Switzerland;S. Karger AG;2004-ongoing;"Dermatology (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Physiology (Q2)"
134;21100370879;Journal of managed care & specialty pharmacy;journal;23761032, 23760540;1.087;Q1;55;65;290;1766;583;187;2.82;27,17;United States;Academy of Managed Care Pharmacy (AMCP);2014-ongoing;"Health Policy (Q1); Pharmaceutical Science (Q1); Pharmacy (Q1)"
135;25786;Bioorganic and Medicinal Chemistry;journal;14643391, 09680896;1.083;Q1;142;906;2450;33587;7946;2424;3.14;37,07;United Kingdom;Elsevier Ltd.;1993-ongoing;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmaceutical Science (Q1); Biochemistry (Q2); Molecular Medicine (Q2); Organic Chemistry (Q2); Molecular Biology (Q3)"
136;25788;Bioorganic and Medicinal Chemistry Letters;journal;14643405, 0960894X;1.08;Q1;133;1632;3910;41715;10955;3858;2.83;25,56;United Kingdom;Elsevier Ltd.;1991-ongoing;"Drug Discovery (Q1); Pharmaceutical Science (Q1); Biochemistry (Q2); Clinical Biochemistry (Q2); Molecular Medicine (Q2); Organic Chemistry (Q2); Molecular Biology (Q3)"
137;29712;Clinical Therapeutics;journal;01492918;1.068;Q1;123;251;850;6997;2837;762;3.22;27,88;United States;Elsevier Inc.;1977-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
138;23035;Journal of Biopharmaceutical Statistics;journal;10543406, 15205711;1.064;Q1;43;86;191;1783;318;169;1.5;20,73;United States;Marcel Dekker Inc.;1991-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Statistics and Probability (Q2)"
139;17067;Phytomedicine;journal;09447113;1.062;Q1;105;195;434;6109;1461;423;3.16;31,33;Netherlands;Elsevier BV;1994-ongoing;"Complementary and Alternative Medicine (Q1); Drug Discovery (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
140;21326;European Journal of Clinical Pharmacology;journal;00316970, 14321041;1.06;Q1;99;187;464;5571;1426;393;3.87;29,79;Germany;Springer Verlag;1968-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
141;19034;Microbial Drug Resistance;journal;10766294;1.054;Q1;62;48;124;1544;277;124;2.32;32,17;United States;Mary Ann Liebert Inc.;1995-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Immunology (Q2); Microbiology (Q2); Microbiology (medical) (Q2)"
142;20427;Naunyn-Schmiedeberg's Archives of Pharmacology;journal;00281298;1.054;Q1;83;104;297;4444;834;292;2.77;42,73;Germany;Springer Verlag;1969-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
143;21333;European Journal of Pharmacology;journal;00142999;1.043;Q2;167;688;2119;29037;6402;2101;3.09;42,20;Netherlands;Elsevier BV;1967-ongoing;Pharmacology (Q2)
144;4700152856;Expert Opinion on Drug Metabolism and Toxicology;journal;17425255;1.043;Q1;72;121;317;10240;1229;310;3.81;84,63;United Kingdom;Informa Healthcare;2005-ongoing;"Medicine (miscellaneous) (Q1); Toxicology (Q1); Pharmacology (Q2)"
145;23155;Current Vascular Pharmacology;journal;15701611;1.04;Q2;54;87;111;9547;424;104;4.18;109,74;United Arab Emirates;Bentham Science Publishers;2003-ongoing;"Cardiology and Cardiovascular Medicine (Q1); Pharmacology (Q2)"
146;9000153111;Comparative Biochemistry and Physiology, Part C;journal;15320456;1.028;Q1;99;124;405;6254;1172;400;2.58;50,44;Netherlands;Elsevier BV;2000-ongoing;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1); Biochemistry (Q2); Physiology (Q2); Cell Biology (Q3)"
147;24786;Alcohol and Alcoholism;journal;07350414, 14643502;1.018;Q1;89;75;304;2810;871;283;2.96;37,47;United Kingdom;Oxford University Press;1965-ongoing;"Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
148;17595;Journal of Biomolecular Screening;journal;10870571;1.017;Q1;69;134;302;3470;820;297;2.85;25,90;United States;Sage Science Press;1996-ongoing;"Drug Discovery (Q1); Analytical Chemistry (Q2); Biochemistry (Q2); Biotechnology (Q2); Molecular Medicine (Q2); Pharmacology (Q2)"
149;19427;Advances in Pharmacology;book series;10543589;1.013;Q2;68;42;44;4899;107;39;1.81;116,64;United States;Elsevier Inc.;1962-1964, 1966-1973, 1975, 1977-1982, 1984, 1990-2000, 2004-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
150;11700154316;CNS Neuroscience and Therapeutics;journal;17555949, 17555930;1.013;Q2;59;53;64;4400;230;59;3.9;83,02;United States;Wiley-Blackwell;2008-ongoing;"Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Pharmacology (Q2); Physiology (medical) (Q2)"
151;20473;Life Sciences;journal;00243205;1.009;Q1;150;231;978;11111;2960;971;2.76;48,10;Netherlands;Elsevier BV;1962-ongoing;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
152;23085;Journal of Pharmacological Sciences;journal;13478648, 13478613;1.008;Q2;74;183;561;6327;1497;550;2.63;34,57;Netherlands;Elsevier BV;1996-ongoing;"Molecular Medicine (Q2); Pharmacology (Q2)"
153;4100151708;Inflammation and Allergy - Drug Targets;journal;18715281;1.004;Q2;42;43;101;4170;371;98;3.92;96,98;United Arab Emirates;Bentham Science Publishers;2006-2015;"Medicine (miscellaneous) (Q1); Immunology (Q2); Immunology and Allergy (Q2); Pharmacology (Q2)"
154;24603;Archives of Environmental Contamination and Toxicology;journal;14320703, 00904341;0.999;Q2;98;183;485;7719;1095;479;2.17;42,18;Germany;Springer Verlag;1973-ongoing;"Medicine (miscellaneous) (Q1); Pollution (Q1); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
155;11900154314;Cardiovascular Therapeutics;journal;17555914, 17555922;0.996;Q2;39;60;71;3320;168;63;2.67;55,33;United States;Wiley-Blackwell;2008-ongoing;"Cardiology and Cardiovascular Medicine (Q1); Medicine (miscellaneous) (Q1); Pharmacology (medical) (Q1); Pharmacology (Q2)"
156;18075;Neurotoxicology and Teratology;journal;08920362;0.995;Q2;89;76;149;4273;479;145;3.02;56,22;Netherlands;Elsevier BV;1987-ongoing;"Developmental Neuroscience (Q2); Toxicology (Q2); Cellular and Molecular Neuroscience (Q3)"
157;18922;Journal of Gene Medicine;journal;1099498X, 15212254;0.991;Q1;87;98;337;3755;1123;328;3.23;38,32;United States;John Wiley & Sons Inc.;1998-ongoing;"Drug Discovery (Q1); Genetics (Q2); Molecular Medicine (Q2); Genetics (clinical) (Q3); Molecular Biology (Q3)"
158;21350;Expert Opinion on Emerging Drugs;journal;14728214, 17447623;0.984;Q2;43;47;121;4968;422;121;3.92;105,70;United Kingdom;Taylor & Francis;2000-ongoing;"Pharmacology (medical) (Q1); Pharmacology (Q2)"
159;19984;Assay and Drug Development Technologies;journal;1540658X;0.966;Q2;52;119;269;1960;423;142;2.72;16,47;United States;Mary Ann Liebert Inc.;2002-ongoing;"Drug Discovery (Q2); Molecular Medicine (Q2)"
160;24652;Chemico-Biological Interactions;journal;00092797;0.959;Q2;108;366;581;15798;1962;568;3.35;43,16;Netherlands;Elsevier BV;1969-ongoing;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
161;130047;Current Drug Discovery Technologies;journal;15701638;0.956;Q2;38;29;90;2418;288;86;3.63;83,38;United Arab Emirates;Bentham Science Publishers;2004-ongoing;Drug Discovery (Q2)
162;21841;Food Additives and Contaminants;journal;0265203X, 14645122;0.941;Q2;90;0;169;0;484;165;0.0;0,00;United Kingdom;Taylor & Francis;1984-2008;"Chemistry (miscellaneous) (Q1); Food Science (Q1); Public Health, Environmental and Occupational Health (Q1); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
163;13845;Bulletin of Mathematical Biology;journal;00928240, 15229602;0.94;Q2;78;91;291;3419;584;284;1.97;37,57;United States;Springer New York LLC;1973-ongoing;"Agricultural and Biological Sciences (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1); Environmental Science (miscellaneous) (Q1); Computational Theory and Mathematics (Q2); Immunology (Q2); Mathematics (miscellaneous) (Q2); Neuroscience (miscellaneous) (Q2); Pharmacology (Q2)"
164;25151;Journal of Toxicology and Environmental Health - Part A;journal;10872620, 15287394;0.939;Q2;80;162;479;6261;1019;468;1.98;38,65;United Kingdom;Taylor & Francis;1996-ongoing;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
165;24797;Mini-Reviews in Medicinal Chemistry;journal;13895575;0.939;Q2;79;107;368;10462;1171;365;3.0;97,78;United Arab Emirates;Bentham Science Publishers;2001-ongoing;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Pharmacology (Q2)"
166;25096;Food and Chemical Toxicology;journal;02786915;0.93;Q2;149;574;1362;22638;4067;1328;3.1;39,44;Netherlands;Elsevier BV;1982-ongoing;"Food Science (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q2)"
167;4700152903;Forensic Toxicology;journal;18608965, 18608973;0.93;Q2;30;21;59;418;95;55;2.31;19,90;Germany;Springer Verlag;2006-ongoing;"Biochemistry (medical) (Q1); Pathology and Forensic Medicine (Q1); Toxicology (Q2)"
168;25176;Regulatory Toxicology and Pharmacology;journal;02732300, 10960295;0.926;Q2;90;153;370;6455;985;331;2.79;42,19;United States;Elsevier Inc.;1981-ongoing;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
169;22982;Journal of Cardiovascular Pharmacology and Therapeutics;journal;10742484;0.923;Q2;44;55;100;2371;266;98;2.66;43,11;United States;SAGE Publications;1996-ongoing;"Cardiology and Cardiovascular Medicine (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
170;22575;Cardiovascular Toxicology;journal;15307905;0.919;Q2;47;36;85;1330;225;84;1.94;36,94;United States;Humana Press, Inc.;2001-ongoing;"Cardiology and Cardiovascular Medicine (Q2); Toxicology (Q2); Molecular Biology (Q3)"
171;25214;Toxicologic Pathology;journal;15331601, 01926233;0.915;Q2;96;118;296;4587;775;265;2.41;38,87;United States;SAGE Publications;1972-ongoing;"Pathology and Forensic Medicine (Q2); Toxicology (Q2); Cell Biology (Q3); Molecular Biology (Q3)"
172;28727;Anti-Cancer Drugs;journal;09594973, 14735741;0.913;Q2;88;126;402;5063;1011;395;2.58;40,18;United States;Lippincott Williams & Wilkins Ltd.;1990-ongoing;"Oncology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2); Cancer Research (Q3)"
173;144956;Drug Metabolism and Pharmacokinetics;journal;13474367, 18800920;0.91;Q1;58;75;169;2601;449;151;2.86;34,68;United Kingdom;Elsevier Limited;2004-ongoing;"Pharmaceutical Science (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
174;16948;Chirality;journal;1520636X, 08990042;0.904;Q2;73;142;359;4819;875;346;2.54;33,94;United States;John Wiley & Sons Inc.;1989-ongoing;"Analytical Chemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Spectroscopy (Q2); Catalysis (Q3)"
175;23081;Journal of Pharmacokinetics and Pharmacodynamics;journal;15738744, 1567567X;0.8959999999999999;Q2;54;38;104;1268;182;102;1.7;33,37;United States;Kluwer Academic/Plenum Publishers;1996-1999, 2001-ongoing;Pharmacology (Q2)
176;24604;Archives of Toxicology;journal;14320738, 03405761;0.895;Q2;96;96;299;6154;903;263;3.76;64,10;Germany;Springer Verlag;1972-ongoing;"Medicine (miscellaneous) (Q1); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
177;22432;International Immunopharmacology;journal;15675769;0.893;Q2;98;235;647;9042;1774;632;2.67;38,48;Netherlands;Elsevier BV;2001-ongoing;"Immunology and Allergy (Q2); Pharmacology (Q2); Immunology (Q3)"
178;16836;BMC Chemical Biology;journal;14726769;0.889;Q2;19;7;12;306;26;12;2.4;43,71;United Kingdom;BioMed Central;2001-2012;"Drug Discovery (Q2); Molecular Medicine (Q2)"
179;17464;European Journal of Medicinal Chemistry;journal;02235234;0.887;Q2;135;766;1071;27203;3898;1061;3.48;35,51;Netherlands;Elsevier BV;1974-ongoing;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2)"
180;22299;Therapeutic Drug Monitoring;journal;15363694, 01634356;0.887;Q2;87;131;329;4200;1038;313;3.48;32,06;United States;Lippincott Williams & Wilkins Ltd.;1979-ongoing;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
181;5800173402;Recent Patents on CNS Drug Discovery;journal;15748898;0.8859999999999999;Q2;29;22;64;2758;190;64;2.88;125,36;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Drug Discovery (Q2); Pharmacology (medical) (Q2); Psychiatry and Mental Health (Q2)"
182;14822;Xenobiotica;journal;00498254, 13665928;0.8809999999999999;Q2;75;86;252;2861;737;248;3.18;33,27;United Kingdom;Taylor & Francis;1971-ongoing;"Medicine (miscellaneous) (Q1); Biochemistry (Q2); Health, Toxicology and Mutagenesis (Q2); Pharmacology (Q2); Toxicology (Q2)"
183;4600151527;Infectious Disorders - Drug Targets;journal;18715265;0.8759999999999999;Q2;49;45;114;3794;283;100;2.55;84,31;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Medicine (miscellaneous) (Q1); Microbiology (medical) (Q2); Molecular Medicine (Q2); Pharmacology (Q2)"
184;22319;Toxicon;journal;00410101;0.872;Q2;116;362;761;16668;2048;736;2.53;46,04;United Kingdom;Elsevier Ltd.;1962-ongoing;Toxicology (Q2)
185;29053;Molecular Diversity;journal;1573501X, 13811991;0.87;Q2;54;89;85;3396;260;80;3.66;38,16;Netherlands;Kluwer Academic Publishers;1995-1998, 2000, 2003-ongoing;"Information Systems (Q1); Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Inorganic Chemistry (Q2); Organic Chemistry (Q2); Physical and Theoretical Chemistry (Q2); Catalysis (Q3); Molecular Biology (Q3)"
186;23479;Journal of Physiology and Pharmacology;journal;08675910, 18991505;0.8690000000000001;Q2;70;92;564;4036;1215;550;2.23;43,87;Poland;Polish Physiological Society;1991-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Physiology (Q2)"
187;5800173387;Reviews on Recent Clinical Trials;journal;15748871;0.858;Q2;30;24;78;1543;192;74;2.33;64,29;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
188;4400151410;Human Vaccines;journal;15548600, 15548619;0.857;Q1;49;184;246;7231;534;199;2.78;39,30;United States;Landes Bioscience;2005-2011;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Immunology (Q3)"
189;4400151415;Cardiovascular and Hematological Agents in Medicinal Chemistry;journal;18715257;0.8420000000000001;Q2;36;20;99;1852;268;98;2.95;92,60;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Medicine (miscellaneous) (Q1); Cardiology and Cardiovascular Medicine (Q2); Hematology (Q2); Pharmacology (Q2)"
190;25224;Toxicology in Vitro;journal;08872333;0.836;Q2;96;274;636;10989;1813;623;2.93;40,11;Netherlands;Elsevier BV;1987-ongoing;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
191;4000150314;Chemical Biology and Drug Design;journal;17470277;0.8320000000000001;-;71;128;367;4925;918;356;2.61;38,48;United Kingdom;Blackwell;2006-ongoing;"Biochemistry (Q2); Molecular Medicine (Q2)"
192;23382;Clinical and Experimental Pharmacology and Physiology;journal;14401681, 03051870;0.8320000000000001;Q2;95;213;638;8737;1489;604;2.22;41,02;United Kingdom;Blackwell Publishing Inc.;1974-ongoing;"Pharmacology (Q2); Physiology (Q2); Physiology (medical) (Q2)"
193;22378;Vascular Pharmacology;journal;15371891;0.8270000000000001;Q2;86;69;224;3721;617;219;2.61;53,93;Netherlands;Elsevier BV;2002-ongoing;"Molecular Medicine (Q2); Pharmacology (Q2); Physiology (Q2)"
194;23453;Combinatorial Chemistry and High Throughput Screening;journal;13862073;0.8220000000000001;Q2;59;100;263;5804;654;236;2.9;58,04;United Arab Emirates;Bentham Science Publishers;1998-ongoing;"Computer Science Applications (Q1); Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Organic Chemistry (Q2)"
195;24785;Alcohol;journal;07418329;0.8190000000000001;Q2;74;74;172;4078;427;167;2.54;55,11;Netherlands;Elsevier BV;1984-ongoing;"Health (social science) (Q1); Medicine (miscellaneous) (Q1); Biochemistry (Q2); Neurology (Q2); Toxicology (Q2); Behavioral Neuroscience (Q3)"
196;130063;Pharmacological Reports;journal;17341140, 22995684;0.8170000000000001;Q2;71;147;369;5766;992;360;2.94;39,22;Netherlands;Elsevier BV;1998-2002, 2005-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
197;18500157900;Food Additives and Contaminants - Part A Chemistry, Analysis, Control, Exposure and Risk Assessment;journal;19440057, 19440049;0.816;Q2;60;179;354;6008;863;347;2.49;33,56;United States;Taylor and Francis;2008-ongoing;"Chemistry (miscellaneous) (Q1); Food Science (Q1); Medicine (miscellaneous) (Q1); Public Health, Environmental and Occupational Health (Q1); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
198;19443;American Journal of Health-System Pharmacy;journal;10792082;0.7979999999999999;Q2;87;409;1245;5833;1706;761;2.35;14,26;United States;American Society of Health-System Pharmacists;1995-ongoing;"Health Policy (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
199;24626;Cell Biology and Toxicology;journal;15736822, 07422091;0.7929999999999999;Q2;56;46;122;2657;338;119;2.82;57,76;Netherlands;Kluwer Academic Publishers;1984-ongoing;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2); Cell Biology (Q3)"
200;21744;Planta Medica;journal;14390221, 00320943;0.778;Q1;103;318;667;9810;1561;645;2.3;30,85;Germany;Georg Thieme Verlag;1961, 1965-ongoing;"Complementary and Alternative Medicine (Q1); Pharmaceutical Science (Q1); Analytical Chemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
201;25093;Environmental Toxicology;journal;15227278, 15204081;0.769;Q2;69;72;210;2945;417;209;1.89;40,90;United States;John Wiley & Sons Inc.;1980, 1999-ongoing;"Management, Monitoring, Policy and Law (Q1); Medicine (miscellaneous) (Q1); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
202;21455;Progress in Medicinal Chemistry;book series;00796468;0.769;Q2;33;6;25;624;35;19;1.67;104,00;Netherlands;Elsevier BV;1961-1963, 1965, 1967, 1969-ongoing;"Pharmacology (Q2); Molecular Medicine (Q3)"
203;25898;Journal of Peptide Science;journal;10752617, 10991387;0.764;Q2;60;101;344;3649;632;332;1.91;36,13;United States;John Wiley & Sons Inc.;1995-ongoing;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Biochemistry (Q3); Molecular Biology (Q3); Molecular Medicine (Q3); Structural Biology (Q3)"
204;25125;Journal of Analytical Toxicology;journal;01464760;0.7609999999999999;Q2;69;90;293;2289;480;271;1.55;25,43;United States;Perston Publications, Inc.;1977-ongoing;"Chemical Health and Safety (Q1); Analytical Chemistry (Q2); Environmental Chemistry (Q2); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
205;19374;AAPS PharmSciTech;journal;15221059, 15309932;0.754;Q1;79;203;403;6366;918;399;1.68;31,36;United States;American Association of Pharmaceutical Scientists;2000-ongoing;"Agronomy and Crop Science (Q1); Pharmaceutical Science (Q1); Aquatic Science (Q2); Drug Discovery (Q2); Ecology (Q2); Ecology, Evolution, Behavior and Systematics (Q2); Medicine (miscellaneous) (Q2)"
206;144790;Marine Drugs;journal;16603397;0.7509999999999999;Q2;84;155;78;11748;335;76;4.48;75,79;Switzerland;Multidisciplinary Digital Publishing Institute (MDPI);2005-ongoing;Drug Discovery (Q2)
207;5800228222;Journal of Pharmaceutical Innovation;journal;18725120;0.746;Q1;25;20;55;509;88;46;1.91;25,45;United States;Springer USA;2006-ongoing;"Pharmaceutical Science (Q1); Drug Discovery (Q2)"
208;20064;Biological and Pharmaceutical Bulletin;journal;13475215, 09186158;0.7440000000000001;Q1;104;367;1179;11246;2606;1164;2.09;30,64;Japan;Pharmaceutical Society of Japan;1993-ongoing;"Pharmaceutical Science (Q1); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
209;25126;Journal of Applied Toxicology;journal;10991263, 0260437X;0.74;Q2;76;93;274;4305;671;267;2.46;46,29;United States;John Wiley & Sons Inc.;1981-ongoing;Toxicology (Q2)
210;16573;Phytotherapy Research;journal;10991573, 0951418X;0.735;Q2;112;389;802;10283;2023;785;2.26;26,43;United States;John Wiley & Sons Inc.;1987-ongoing;Pharmacology (Q2)
211;5800173383;Current Clinical Pharmacology;journal;15748847;0.732;Q1;33;32;66;2531;174;65;2.62;79,09;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2)"
212;28620;Biomedicine and Pharmacotherapy;journal;07533322;0.728;Q2;78;126;321;4042;809;311;2.44;32,08;France;Elsevier Masson;1982-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
213;4200151509;Molecular Diagnosis and Therapy;journal;11771062;0.725;Q2;34;43;101;1711;263;97;3.16;39,79;United Kingdom;Adis International Ltd.;2006-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Genetics (Q3); Molecular Medicine (Q3)"
214;20047;Basic and Clinical Pharmacology and Toxicology;journal;17427835;0.7240000000000001;Q2;80;143;419;5065;1072;406;2.71;35,42;United States;Wiley-Blackwell;2004-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Toxicology (Q2)"
215;22411;Inflammopharmacology;journal;09254692, 15685608;0.723;Q2;45;35;126;1442;306;123;3.26;41,20;Switzerland;Birkhauser Verlag;1991-ongoing;"Pharmacology (Q2); Pharmacology (medical) (Q2); Immunology (Q3)"
216;16067;Reading Teacher;journal;00340561;0.721;Q2;44;85;221;1516;168;219;0.77;17,84;United States;Wiley-Blackwell;1995-ongoing;"Language and Linguistics (Q1); Linguistics and Language (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
217;14487;Journal of Ocular Pharmacology and Therapeutics;journal;10807683;0.718;Q2;53;94;207;2599;460;200;2.33;27,65;United States;Mary Ann Liebert Inc.;1995-ongoing;"Ophthalmology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
218;23363;Canadian Journal of Physiology and Pharmacology;journal;00084212, 12057541;0.715;Q2;77;150;327;5885;682;318;2.12;39,23;Canada;NRC Research Press;1964-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Physiology (medical) (Q2); Physiology (Q3)"
219;14805;Steroids;journal;0039128X;0.715;Q2;95;158;430;6582;1441;421;3.35;41,66;Netherlands;Elsevier BV;1963-ongoing;"Clinical Biochemistry (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Biochemistry (Q3); Endocrinology (Q3); Molecular Biology (Q3)"
220;28636;Birth Defects Research Part B - Developmental and Reproductive Toxicology;journal;15429733, 15429741;0.71;Q2;54;57;103;2873;262;90;2.64;50,40;United States;John Wiley & Sons Inc.;2003-ongoing;"Embryology (Q2); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2); Developmental Biology (Q3)"
221;23942;Biomedical Chromatography;journal;10990801, 02693879;0.7090000000000001;Q2;58;190;530;4524;901;513;1.55;23,81;United States;John Wiley & Sons Inc.;1986-ongoing;"Analytical Chemistry (Q2); Clinical Biochemistry (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Biochemistry (Q3); Molecular Biology (Q3)"
222;4600151526;Cardiovascular and Hematological Disorders - Drug Targets;journal;1871529X;0.705;Q2;37;34;93;3265;200;91;1.92;96,03;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Cardiology and Cardiovascular Medicine (Q2); Hematology (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
223;21190;Drug Development and Industrial Pharmacy;journal;03639045, 15205762;0.7040000000000001;Q2;78;160;414;5601;749;406;1.72;35,01;United States;Marcel Dekker Inc.;1974, 1976-ongoing;"Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2)"
224;29953;Journal of Experimental Therapeutics and Oncology;journal;13594117;0.6990000000000001;Q2;36;17;69;546;136;68;2.23;32,12;United States;Old City Publishing Inc.;1996, 2002-ongoing;"Drug Discovery (Q2); Pharmacology (Q2); Cancer Research (Q3)"
225;19600166302;Current molecular pharmacology;journal;18744702;0.69;Q2;34;14;48;1728;115;48;2.4;123,43;United Arab Emirates;Bentham Science Publishers;2008-ongoing;"Drug Discovery (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
226;21353;Expert Opinion on Therapeutic Patents;journal;13543776;0.687;Q2;61;119;282;9662;565;272;2.64;81,19;United Kingdom;Taylor & Francis;1991-ongoing;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
227;20026;BMC Clinical Pharmacology;journal;14726904;0.679;Q2;35;16;44;462;130;44;2.2;28,88;United Kingdom;BioMed Central;2001-2012;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
228;25095;Environmental Toxicology and Pharmacology;journal;13826689;0.677;Q2;72;92;349;4087;608;346;1.56;44,42;Netherlands;Elsevier BV;1996-ongoing;"Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Toxicology (Q2)"
229;4000148406;Clinical Toxicology;journal;15563650;0.674;Q2;85;166;470;3887;774;376;2.06;23,42;United Kingdom;Taylor & Francis;1968-1998, 2005-ongoing;"Medicine (miscellaneous) (Q2); Toxicology (Q2)"
230;25789;Bioorganic Chemistry;journal;00452068, 10902120;0.6729999999999999;Q2;50;45;102;1592;190;100;1.52;35,38;United States;Elsevier Inc.;1971-ongoing;"Drug Discovery (Q2); Organic Chemistry (Q2); Biochemistry (Q3); Molecular Biology (Q3)"
231;130025;Current Drug Delivery;journal;15672018;0.6729999999999999;Q1;54;51;133;1910;364;132;1.74;37,45;United Arab Emirates;Bentham Science Publishers;2004-ongoing;Pharmaceutical Science (Q1)
232;28794;Cancer Biotherapy and Radiopharmaceuticals;journal;10849785;0.6679999999999999;Q2;55;98;230;3036;418;222;2.28;30,98;United States;Mary Ann Liebert Inc.;1996-ongoing;"Medicine (miscellaneous) (Q2); Oncology (Q2); Pharmacology (Q2); Radiology, Nuclear Medicine and Imaging (Q2); Cancer Research (Q3)"
233;19403;Acta Pharmacologica Sinica;journal;16714083, 17457254;0.667;Q2;78;212;598;8634;1226;589;2.01;40,73;United States;Nature Publishing Group;1980-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
234;16319;IEEE Transactions on Nanobioscience;journal;15361241;0.6659999999999999;Q1;55;35;115;1232;333;110;2.83;35,20;United States;Institute of Electrical and Electronics Engineers;2002-ongoing;"Electrical and Electronic Engineering (Q1); Pharmaceutical Science (Q1); Bioengineering (Q2); Biomedical Engineering (Q2); Biotechnology (Q2); Computer Science Applications (Q2); Medicine (miscellaneous) (Q2); Nanoscience and Nanotechnology (Q2)"
235;22410;Inflammation Research;journal;1420908X, 10233830;0.664;Q2;82;153;370;4995;659;365;1.7;32,65;Switzerland;Birkhauser Verlag;1995-ongoing;"Pharmacology (Q2); Immunology (Q3)"
236;23007;Journal of Clinical Pharmacy and Therapeutics;journal;13652710, 02694727;0.664;Q2;65;82;259;2538;582;240;2.11;30,95;United Kingdom;Blackwell Publishing Inc.;1976-ongoing;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
237;25146;Journal of Pharmacological and Toxicological Methods;journal;10568719;0.664;Q2;64;76;188;2902;464;184;2.59;38,18;Netherlands;Elsevier BV;1992-2002, 2004-ongoing;"Pharmacology (Q2); Toxicology (Q2)"
238;20570;Chemotherapy;journal;00093157, 14219794;0.662;Q2;49;76;175;2260;386;170;2.34;29,74;Switzerland;S. Karger AG;1963-ongoing;"Drug Discovery (Q2); Infectious Diseases (Q2); Medicine (miscellaneous) (Q2); Oncology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
239;29550;Journal of Biochemical and Molecular Toxicology;journal;10956670, 10990461;0.6609999999999999;Q2;53;46;139;1902;280;133;1.72;41,35;United States;John Wiley & Sons Inc.;1998-ongoing;"Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Toxicology (Q2); Biochemistry (Q3); Molecular Biology (Q3); Molecular Medicine (Q3)"
240;21352;Expert Opinion on Pharmacotherapy;journal;14656566;0.66;Q2;69;291;769;19205;1958;739;2.74;66,00;United Kingdom;Taylor & Francis;1999-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
241;16533;Phytochemical Analysis;journal;09580344, 10991565;0.6559999999999999;Q2;63;77;198;2083;378;195;1.91;27,05;United States;John Wiley & Sons Inc.;1990-ongoing;"Complementary and Alternative Medicine (Q1); Food Science (Q1); Analytical Chemistry (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Plant Science (Q2); Biochemistry (Q3); Molecular Medicine (Q3)"
242;23102;Journal of Pharmacy and Pharmacology;journal;00223573;0.655;Q1;107;196;479;8167;1097;469;2.35;41,67;United States;Wiley-Blackwell;1949-ongoing;"Pharmaceutical Science (Q1); Pharmacology (Q2)"
243;20027;BMC Pharmacology;journal;14712210;0.649;Q2;38;16;49;550;103;49;2.21;34,38;United Kingdom;BioMed Central;2001-2012;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
244;25149;Journal of Toxicological Sciences;journal;18803989, 03881350;0.649;Q2;44;110;235;2912;424;225;1.98;26,47;Japan;Japanese Society of Toxicological Sciences;1976-ongoing;"Medicine (miscellaneous) (Q2); Toxicology (Q2)"
245;110172;Progress in Drug Research;book series;0071786X;0.648;Q1;38;0;33;0;100;30;4.11;0,00;Switzerland;Birkhauser Verlag;1959-1966, 1968-1969, 1972-2003, 2005, 2007-2008, 2011, 2014-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Medicine (miscellaneous) (Q2); Molecular Medicine (Q3)"
246;23039;Journal of Liposome Research;journal;08982104, 15322394;0.647;Q1;44;38;70;1418;137;67;1.95;37,32;United States;Marcel Dekker Inc.;1988-1990, 1992-ongoing;Pharmaceutical Science (Q1)
247;11500153306;Recent Patents on Drug Delivery and Formulation;journal;18722113;0.645;Q1;25;18;46;2101;103;46;1.76;116,72;United Arab Emirates;Bentham Science Publishers;2007-ongoing;"Pharmaceutical Science (Q1); Biomedical Engineering (Q2); Medicine (miscellaneous) (Q2)"
248;21865;Fundamental and Clinical Pharmacology;journal;07673981;0.642;Q2;64;88;251;4181;515;236;2.16;47,51;United Kingdom;Blackwell Publishing Inc.;1987-ongoing;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
249;21194;Pharmacology;journal;00317012, 14230313;0.636;Q2;54;92;257;3377;478;231;1.99;36,71;Switzerland;S. Karger AG;1968-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
250;20602;Clinical Neuropharmacology;journal;03625664;0.634;Q2;74;78;213;1991;466;181;2.02;25,53;United States;Lippincott Williams & Wilkins Ltd.;1982-ongoing;"Neurology (clinical) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
251;18077;Fitoterapia;journal;0367326X;0.631;Q2;90;227;365;6349;811;363;2.14;27,97;Netherlands;Elsevier BV;1948-1949, 1961, 1972-ongoing;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
252;21229;Drug News and Perspectives;journal;02140934;0.629;Q2;47;73;210;4193;366;206;1.85;57,44;Spain;J.R. Prous;1990-2010;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
253;27087;American Journal of Therapeutics;journal;10752765, 15363686;0.625;Q2;55;119;272;4100;442;250;1.68;34,45;United States;Lippincott Williams & Wilkins Ltd.;1960-1961, 1996-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
254;15840;Journal of Antibiotics;journal;00218820;0.619;Q2;73;145;326;3202;530;304;1.73;22,08;United Kingdom;Nature Publishing Group;1953-ongoing;"Drug Discovery (Q2); Pharmacology (Q2)"
255;20770;Drug Delivery;journal;10717544;0.618;Q1;52;66;171;2481;302;168;1.47;37,59;United Kingdom;Taylor & Francis;1993, 1995-ongoing;"Pharmaceutical Science (Q1); Medicine (miscellaneous) (Q2)"
256;10300153342;Journal of medical toxicology : official journal of the American College of Medical Toxicology;journal;15569039;0.615;Q2;41;97;120;1859;178;104;1.73;19,16;United States;Springer New York LLC;2005-ongoing;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
257;23089;Journal of Pharmacy and Pharmaceutical Sciences;journal;14821826;0.615;Q1;69;51;129;2176;267;126;2.21;42,67;Canada;Canadian Society for Pharmaceutical Sciences;1998-ongoing;"Pharmaceutical Science (Q1); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
258;21099;Pharmaceutical Development and Technology;journal;10837450, 10979867;0.612;Q1;50;74;157;2198;212;155;1.16;29,70;United States;Marcel Dekker Inc.;1996-ongoing;"Pharmaceutical Science (Q1); Medicine (miscellaneous) (Q2)"
259;4700152612;Current Nanoscience;journal;15734137;0.61;Q1;37;88;122;4067;296;121;2.7;46,22;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Pharmaceutical Science (Q1); Bioengineering (Q2); Biomedical Engineering (Q2); Biotechnology (Q2); Medicine (miscellaneous) (Q2); Nanoscience and Nanotechnology (Q2)"
260;22769;Chemical and Pharmaceutical Bulletin;journal;00092363, 13475223;0.604;Q2;84;335;930;8481;1700;925;1.69;25,32;Japan;Pharmaceutical Society of Japan;1958, 1962-ongoing;"Chemistry (miscellaneous) (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2)"
261;13248;Experimental and Toxicologic Pathology;journal;09402993;0.604;Q2;58;78;192;2869;394;186;2.28;36,78;Netherlands;Elsevier BV;1992-ongoing;"Medicine (miscellaneous) (Q2); Pathology and Forensic Medicine (Q2); Toxicology (Q2); Cell Biology (Q3)"
262;13671;Biologicals;journal;10958320, 10451056;0.602;Q2;51;113;171;3214;325;157;2.16;28,44;United States;Elsevier Inc.;1990-ongoing;"Applied Microbiology and Biotechnology (Q2); Bioengineering (Q2); Biotechnology (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Immunology and Microbiology (miscellaneous)  (Q3)"
263;11700154735;Journal of Aerosol Medicine and Pulmonary Drug Delivery;journal;19412711;0.598;Q1;61;60;131;2336;240;112;2.52;38,93;United States;Mary Ann Liebert Inc.;2008-ongoing;"Pharmaceutical Science (Q1); Pharmacology (medical) (Q2); Pulmonary and Respiratory Medicine (Q2)"
264;19700174918;Clinical and Translational Science;journal;17528062, 17528054;0.596;Q1;35;86;188;1424;182;120;1.52;16,56;United States;Wiley-Blackwell;2008-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Neuroscience (miscellaneous) (Q3)"
265;15462;Biotechnology and Applied Biochemistry;journal;14708744, 08854513;0.594;Q2;62;60;213;2377;418;211;1.88;39,62;United States;Wiley-Blackwell;1986-ongoing;"Applied Microbiology and Biotechnology (Q2); Biomedical Engineering (Q2); Biotechnology (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Process Chemistry and Technology (Q2); Bioengineering (Q3); Molecular Medicine (Q3)"
266;24074;Helvetica Chimica Acta;journal;0018019X, 15222675;0.591;Q2;79;281;687;6880;1019;685;1.39;24,48;United States;Wiley-Blackwell;1918-ongoing;"Drug Discovery (Q2); Organic Chemistry (Q2); Biochemistry (Q3); Catalysis (Q3); Inorganic Chemistry (Q3); Physical and Theoretical Chemistry (Q3)"
267;16803;Antiviral Chemistry and Chemotherapy;journal;09563202;0.59;Q2;46;23;64;980;132;60;2.21;42,61;United Kingdom;SAGE Publications Inc.;2017-ongoing, 1991-ongoing;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Virology (Q3)"
268;19900192900;Molecular Informatics;journal;18681751, 18681743;0.59;Q2;60;67;320;3154;696;306;1.71;47,07;Germany;Wiley - VCH Verlag GmbH & CO. KGaA;2010-ongoing;"Computer Science Applications (Q2); Drug Discovery (Q2); Molecular Medicine (Q3); Organic Chemistry (Q3); Structural Biology (Q3)"
269;24624;Bulletin of Environmental Contamination and Toxicology;journal;00074861, 14320800;0.589;Q3;63;280;780;5126;1040;772;1.34;18,31;Germany;Springer Verlag;1966-ongoing;"Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Pollution (Q2); Toxicology (Q3)"
270;4700152233;Therapeutics and Clinical Risk Management;journal;11766336;0.586;Q1;43;17;337;972;702;328;2.19;57,18;New Zealand;Dove Medical Press Ltd;2006-ongoing;"Chemical Health and Safety (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Safety Research (Q1); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2)"
271;19956;Archiv der Pharmazie;journal;15214184, 03656233;0.579;Q1;54;70;233;2120;434;230;1.86;30,29;United Kingdom;John Wiley & Sons Ltd.;1959-1965, 1972-ongoing;"Pharmaceutical Science (Q1); Drug Discovery (Q2)"
272;11700154733;Journal of Biomedical Nanotechnology;journal;15507033;0.573;Q1;64;79;170;3787;404;163;2.71;47,94;United States;American Scientific Publishers;2007-ongoing;"Pharmaceutical Science (Q1); Biomedical Engineering (Q2); Materials Science (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Bioengineering (Q3); Nanoscience and Nanotechnology (Q3)"
273;19398;Acta Pharmaceutica;journal;13300075;0.57;Q1;49;40;104;788;235;104;2.04;19,70;Croatia;Hrvatsko Farmaceutsko Drustvo/Croatian Pharmaceutical Society;1992-ongoing;"Pharmaceutical Science (Q1); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
274;23412;Journal of AOAC International;journal;10603271;0.57;Q2;79;245;555;6179;751;545;1.26;25,22;United States;AOAC International;1993-ongoing;"Agronomy and Crop Science (Q2); Analytical Chemistry (Q2); Food Science (Q2); Pharmacology (Q2); Environmental Chemistry (Q3)"
275;19700182275;International Journal of Clinical Pharmacy;journal;22107711, 22107703;0.569;Q2;52;109;237;2651;369;220;1.68;24,32;Germany;Springer Verlag;2010-ongoing;"Pharmacy (Q1); Pharmaceutical Science (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2); Toxicology (Q3)"
276;26370;Molecules;journal;14203049;0.565;Q2;116;652;824;28792;1944;804;2.19;44,16;Switzerland;Multidisciplinary Digital Publishing Institute (MDPI);1996-ongoing;"Analytical Chemistry (Q2); Chemistry (miscellaneous) (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Molecular Medicine (Q3); Organic Chemistry (Q3); Physical and Theoretical Chemistry (Q3)"
277;19700185200;Journal of Natural Medicines;journal;18610293;0.564;Q2;37;85;204;1679;349;202;1.88;19,75;Germany;Springer Verlag;2006-ongoing;"Complementary and Alternative Medicine (Q1); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Organic Chemistry (Q3)"
278;21273;Journal of Immune Based Therapies and Vaccines;journal;14768518;0.56;Q2;18;9;24;277;42;23;2.25;30,78;United Kingdom;BioMed Central;2003-2011;"Pharmacology (Q2); Immunology (Q3)"
279;19958;Archives of Pharmacal Research;journal;02536269;0.5579999999999999;Q2;75;255;668;8021;1226;653;1.84;31,45;South Korea;Pharmaceutical Society of Korea;1978-ongoing;"Drug Discovery (Q2); Molecular Medicine (Q3); Organic Chemistry (Q3)"
280;23129;Journal of Veterinary Pharmacology and Therapeutics;journal;01407783, 13652885;0.556;Q2;54;91;372;2956;383;368;0.94;32,48;United Kingdom;Blackwell Publishing Inc.;1978-ongoing;"Pharmacology (Q2); Veterinary (miscellaneous) (Q2)"
281;29845;IARC Monographs on the Evaluation of Carcinogenic Risks to Humans;journal;10171606;0.5529999999999999;Q3;38;78;22;8855;39;21;1.0;113,53;France;International Agency for Research on Cancer;1988-1997, 1999-2002, 2004, 2006-2008, 2010-ongoing;"Cancer Research (Q3); Toxicology (Q3)"
282;25111;International Journal of Toxicology;journal;10915818, 1092874X;0.551;Q3;51;76;178;3630;324;167;1.7;47,76;United States;SAGE Publications;1982-ongoing;Toxicology (Q3)
283;6800153101;Expert Opinion on Drug Discovery;journal;1746045X, 17460441;0.5479999999999999;Q2;50;91;329;7820;530;320;1.58;85,93;United Kingdom;Informa Healthcare;2006-ongoing;Drug Discovery (Q2)
284;24578;Mathematical Medicine and Biology;journal;14778599;0.544;Q2;40;7;62;257;75;62;1.22;36,71;United Kingdom;Oxford University Press;1984-1995, 2003-ongoing;"Applied Mathematics (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Environmental Science (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Modeling and Simulation (Q2); Pharmacology (Q2); Immunology and Microbiology (miscellaneous)  (Q3); Neuroscience (miscellaneous) (Q3)"
285;25864;Heterocycles;journal;03855414;0.534;Q2;61;386;1055;13529;1226;1037;1.2;35,05;Netherlands;Elsevier BV;1983, 1985-ongoing;"Pharmacology (Q2); Analytical Chemistry (Q3); Organic Chemistry (Q3)"
286;5800173401;Current Bioactive Compounds;journal;15734072;0.532;Q1;21;22;70;1777;101;62;1.52;80,77;United Arab Emirates;Bentham Science Publishers;2007-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)
287;5900153312;Recent Patents on Cardiovascular Drug Discovery;journal;15748901;0.531;Q2;25;27;79;2260;144;79;1.4;83,70;United Arab Emirates;Bentham Science Publishers;2006-2015;"Cardiology and Cardiovascular Medicine (Q2); Drug Discovery (Q2); Pharmacology (medical) (Q2)"
288;20634;Journal of Texture Studies;journal;00224901;0.521;Q2;48;52;118;1644;112;115;0.72;31,62;United States;Wiley-Blackwell;1969-ongoing;"Food Science (Q2); Pharmaceutical Science (Q2)"
289;21264;Drugs in R and D;journal;11745886;0.516;Q2;39;29;85;821;190;83;2.48;28,31;United Kingdom;Adis International Ltd.;1999, 2002-2008, 2010-ongoing;Pharmacology (Q2)
290;21256;Drugs of Today;journal;16993993, 16994019;0.516;Q2;46;93;224;4148;407;219;1.7;44,60;Spain;Prous Science;1968, 1978-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
291;6400153120;Chinese Medicine;journal;17498546;0.515;Q2;34;43;52;1653;128;49;2.03;38,44;United Kingdom;BioMed Central;2006-ongoing;"Complementary and Alternative Medicine (Q1); Pharmacology (Q2)"
292;26568;International Journal of Cosmetic Science;journal;01425463, 14682494;0.509;Q2;53;45;126;1752;259;120;2.36;38,93;United Kingdom;Blackwell Publishing Inc.;1979-ongoing;"Chemistry (miscellaneous) (Q2); Dermatology (Q2); Drug Discovery (Q2); Pharmaceutical Science (Q2); Aging (Q3); Colloid and Surface Chemistry (Q3)"
293;24640;Journal of Liquid Chromatography and Related Technologies;journal;1520572X, 10826076;0.509;Q2;46;139;617;3528;678;609;1.07;25,38;United States;Marcel Dekker Inc.;1996-ongoing;"Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Biochemistry (Q3); Clinical Biochemistry (Q3)"
294;4700152609;Current Computer-Aided Drug Design;journal;15734099;0.508;Q3;24;23;75;1569;127;70;1.71;68,22;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Medicine (miscellaneous) (Q2); Drug Discovery (Q3); Molecular Medicine (Q3)"
295;5800173386;Current Drug Safety;journal;15748863;0.508;Q2;31;53;105;2846;211;94;2.36;53,70;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Pharmacology (Q2); Pharmacology (medical) (Q2); Toxicology (Q3)"
296;23050;Journal of Microencapsulation;journal;02652048, 14645246;0.504;Q2;70;78;196;2541;307;195;1.62;32,58;United Kingdom;Taylor & Francis;1984-ongoing;"Pharmaceutical Science (Q2); Bioengineering (Q3); Colloid and Surface Chemistry (Q3); Organic Chemistry (Q3); Physical and Theoretical Chemistry (Q3)"
297;5800173403;Recent Patents on Anti-Infective Drug Discovery;journal;1574891X;0.504;Q3;27;21;59;2577;125;59;2.1;122,71;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Drug Discovery (Q3); Infectious Diseases (Q3)"
298;4700152426;Current Pharmaceutical Analysis;journal;15734129;0.503;Q2;22;23;76;2385;134;75;2.04;103,70;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Pharmaceutical Science (Q2); Biochemistry (Q3); Biophysics (Q3); Molecular Medicine (Q3)"
299;19300156901;Dose-Response;journal;15593258;0.501;Q3;30;44;40;2031;130;40;3.25;46,16;United States;International Dose-Response Society;2008-ongoing;"Chemical Health and Safety (Q2); Public Health, Environmental and Occupational Health (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
300;18200156711;Bangladesh Journal of Pharmacology;journal;1991007X, 19910088;0.4970000000000001;Q2;19;22;34;357;49;34;1.44;16,23;Bangladesh;Bangladesh Pharmacological Society;2009-ongoing;Pharmacology (Q2)
301;20580;Journal of Food Biochemistry;journal;01458884;0.494;Q2;40;109;142;3836;125;142;0.74;35,19;United States;Wiley-Blackwell;1977-ongoing;"Food Science (Q2); Pharmacology (Q2); Biophysics (Q3); Cell Biology (Q4)"
302;11000153762;Journal of Immunotoxicology;journal;1547691X, 15476901;0.485;Q3;32;39;106;2004;171;103;1.86;51,38;United States;Taylor and Francis;2004-ongoing;"Immunology (Q3); Toxicology (Q3)"
303;145580;International Journal of Peptide Research and Therapeutics;journal;15733149, 15733904;0.484;Q3;30;37;137;1096;161;133;1.19;29,62;Germany;Springer Verlag;1996-2002, 2005-ongoing;"Analytical Chemistry (Q3); Biochemistry (Q3); Bioengineering (Q3); Drug Discovery (Q3); Molecular Medicine (Q3)"
304;28675;Brazilian Journal of Medical and Biological Research;journal;0100879X;0.476;Q1;79;173;547;5470;852;531;1.35;31,62;Brazil;Associacao Brasileira de Divulgacao Cientifica;1973-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Medicine (miscellaneous) (Q2); Biochemistry (Q3); Biophysics (Q3); Immunology (Q3); Neuroscience (miscellaneous) (Q3); Physiology (Q3); Cell Biology (Q4)"
305;19700174974;Future Medicinal Chemistry;journal;17568919, 17568927;0.476;Q2;54;143;121;10130;124;88;1.41;70,84;United Kingdom;Future Medicine Ltd.;2009-ongoing;"Pharmacology (Q2); Drug Discovery (Q3); Molecular Medicine (Q3)"
306;15300154846;Journal of Occupational Medicine and Toxicology;journal;17456673;0.474;Q3;33;30;84;1000;163;83;1.74;33,33;United Kingdom;BioMed Central;2006-ongoing;"Safety Research (Q1); Public Health, Environmental and Occupational Health (Q2); Toxicology (Q3)"
307;20066;Biopharmaceutics and Drug Disposition;journal;1099081X, 01422782;0.47;Q2;54;42;152;1732;248;152;1.6;41,24;United States;John Wiley & Sons Inc.;1979-ongoing;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
308;21100389517;Drug Metabolism and Personalized Therapy;journal;23638907, 23638915;0.468;Q1;32;6;49;264;101;47;2.06;44,00;Germany;Walter de Gruyter GmbH;2015-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacology (medical) (Q2)"
309;25106;Human and Experimental Toxicology;journal;09603271;0.465;Q3;71;127;351;3924;526;322;1.32;30,90;United States;SAGE Publications;1981-ongoing;"Medicine (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
310;19447;Journal of the American Pharmacists Association : JAPhA;journal;15443191, 15443450;0.465;Q2;58;125;346;2242;310;307;1.19;17,94;United States;Elsevier Inc.;2003-ongoing;"Pharmacology (nursing) (Q1); Pharmacy (Q1); Pharmacology (Q2)"
311;29947;Journal of Chemotherapy;journal;1120009X;0.464;Q2;45;92;354;2498;424;317;1.36;27,15;United Kingdom;Maney Publishing;1989-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2); Infectious Diseases (Q3); Oncology (Q3)"
312;25129;Journal of Environmental Pathology, Toxicology and Oncology;journal;07318898;0.462;Q3;43;33;81;1264;117;81;1.23;38,30;United States;Begell House;1984-1990, 1992-ongoing;"Medicine (miscellaneous) (Q2); Pathology and Forensic Medicine (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
313;11400153335;Recent Patents on Inflammation and Allergy Drug Discovery;journal;1872213X;0.461;Q3;21;29;70;2446;119;70;2.1;84,34;United Arab Emirates;Bentham Science Publishers;2007-ongoing;"Medicine (miscellaneous) (Q2); Drug Discovery (Q3); Immunology and Allergy (Q3)"
314;4700151615;Scandinavian Journal of Work, Environment and Health, Supplement;journal;03566528;0.456;Q3;18;0;91;0;132;71;2.31;0,00;Finland;Nordic Association of Occupational Safety and Health (NOROSH);2005-2011, 2016-ongoing;"Geography, Planning and Development (Q2); Public Health, Environmental and Occupational Health (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
315;26766;ATLA Alternatives to Laboratory Animals;journal;02611929;0.447;Q3;55;95;274;2327;297;216;1.37;24,49;United Kingdom;Fund for the Replacement of Animals in Medical Experiments;1982, 1985-1986, 1988-1989, 1994-ongoing;"Medical Laboratory Technology (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Toxicology (Q3)"
316;17605;Journal of Enzyme Inhibition and Medicinal Chemistry;journal;14756374, 14756366;0.445;Q2;61;118;384;3785;648;379;1.6;32,08;United Kingdom;Taylor & Francis;1985-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Drug Discovery (Q3)"
317;27210;In Vivo;journal;0258851X;0.442;Q2;54;157;379;4212;516;368;1.35;26,83;Greece;International Institute of Anticancer Research;1987-ongoing;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
318;22434;International Journal of Clinical Pharmacology and Therapeutics;journal;09461965;0.436;Q3;62;154;275;2797;417;255;1.54;18,16;Germany;Dustri-Verlag Dr. Karl Feistle;1994-ongoing;"Pharmacology (medical) (Q2); Pharmacology (Q3)"
319;25305;SAR and QSAR in Environmental Research;journal;1029046X, 1062936X;0.435;Q3;42;44;124;2032;264;119;1.99;46,18;United Kingdom;Taylor & Francis;1993-ongoing;"Medicine (miscellaneous) (Q2); Bioengineering (Q3); Drug Discovery (Q3); Molecular Medicine (Q3)"
320;4700152603;Medicinal Chemistry;journal;15734064;0.418;Q3;39;48;207;1854;336;207;1.57;38,63;United Arab Emirates;Bentham Science Publishers;2005-ongoing;Drug Discovery (Q3)
321;22392;Indian Journal of Pharmaceutical Sciences;journal;0250474X, 19983743;0.412;Q2;50;163;516;3071;717;515;1.01;18,84;India;Medknow Publications;1978-ongoing;Pharmaceutical Science (Q2)
322;18800156720;Dissolution Technologies;journal;1521298X;0.41;Q2;28;30;53;358;50;48;1.1;11,93;United States;Dissolution Technologies, Inc.;2008-ongoing;Pharmaceutical Science (Q2)
323;4100151616;Supportive Cancer Therapy;journal;15432912;0.41;Q3;13;0;28;0;40;26;0.0;0,00;United States;Cancer Information Group;2006-2007;"Cancer Research (Q3); Oncology (Q3); Pharmacology (Q3)"
324;20545;PDA Journal of Pharmaceutical Science and Technology;journal;10797440;0.409;Q2;33;72;144;1227;114;134;0.72;17,04;United States;Parenteral Drug Association Inc;1994-ongoing;Pharmaceutical Science (Q2)
325;26767;Altex;journal;1868596X, 18688551;0.407;Q3;45;30;138;794;162;126;2.11;26,47;Germany;Spektrum Akademischer Verlag GmbH;2000-ongoing;"Medical Laboratory Technology (Q1); Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
326;37697;Autonomic and Autacoid Pharmacology;journal;14748665;0.406;Q3;30;27;53;384;58;51;1.48;14,22;United Kingdom;Blackwell Publishing Inc.;2002-ongoing;Pharmacology (Q3)
327;19700175230;Drug Design, Development and Therapy;journal;11778881;0.404;Q2;48;35;51;2438;82;48;1.71;69,66;New Zealand;Dove Medical Press Ltd;2007-ongoing;"Pharmaceutical Science (Q2); Drug Discovery (Q3); Pharmacology (Q3)"
328;24043;Journal of Labelled Compounds and Radiopharmaceuticals;journal;03624803, 10991344;0.403;Q3;41;169;358;2850;298;354;1.05;16,86;United States;John Wiley & Sons Inc.;1976-ongoing;"Analytical Chemistry (Q3); Biochemistry (Q3); Drug Discovery (Q3); Organic Chemistry (Q3); Radiology, Nuclear Medicine and Imaging (Q3); Spectroscopy (Q3)"
329;19444;American Journal of Pharmaceutical Education;journal;15536467, 00029459;0.397;Q1;52;235;407;2862;533;366;1.35;12,18;United States;American Association of Colleges of Pharmacy;1947-1948, 1973-1989, 1991, 1996-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Education (Q2); Medicine (miscellaneous) (Q2)"
330;23348;Journal of Environmental Biology;journal;23940379, 02548704;0.397;Q3;40;165;501;5065;468;478;0.89;30,70;India;Academy of Environmental Biology;1988-ongoing;"Environmental Engineering (Q3); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
331;24071;Metal-Based Drugs;journal;07930291, 16875486;0.395;Q3;33;4;24;266;46;22;2.44;66,50;Egypt;Hindawi Publishing Corporation;1996-2002, 2007-2011;"Drug Discovery (Q3); Inorganic Chemistry (Q3); Pharmacology (Q3); Toxicology (Q3)"
332;19927;Methods and Findings in Experimental and Clinical Pharmacology;journal;03790355;0.394;Q3;47;86;206;3337;250;205;1.02;38,80;Spain;Prous Science;1979-2010;"Pharmacology (medical) (Q2); Pharmacology (Q3)"
333;3500148011;Journal of Zhejiang University: Science B;journal;16731581;0.391;Q1;45;128;386;3667;561;382;1.29;28,65;China;Zhejiang University Press;2005-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Veterinary (miscellaneous) (Q2)"
334;4700151922;Research in Social and Administrative Pharmacy;journal;15517411;0.387;Q2;37;38;96;1129;104;88;0.94;29,71;Netherlands;Elsevier BV;2005-ongoing;"Pharmacy (Q1); Pharmaceutical Science (Q2)"
335;29634;Journal of Negative Results in BioMedicine;journal;14775751;0.375;Q1;19;10;31;342;34;29;1.1;34,20;United Kingdom;BioMed Central;2002-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2)"
336;21192;Drug Development Research;journal;02724391, 10982299;0.374;Q3;54;64;163;2363;171;146;1.25;36,92;United States;John Wiley & Sons Inc.;1981-ongoing;Drug Discovery (Q3)
337;19383;Fluoride - Quarterly Reports;journal;00154725;0.371;Q3;41;38;120;766;103;111;0.93;20,16;New Zealand;International Society for Flouride Research;1973-ongoing;"Agricultural and Biological Sciences (miscellaneous) (Q2); Chemistry (miscellaneous) (Q2); Dentistry (miscellaneous) (Q2); Public Health, Environmental and Occupational Health (Q2); Biochemistry (Q3); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
338;22372;Immunopharmacology and Immunotoxicology;journal;15322513, 08923973;0.37;Q3;42;99;168;3961;189;164;1.04;40,01;United States;Marcel Dekker Inc.;1978-ongoing;"Medicine (miscellaneous) (Q2); Immunology (Q3); Immunology and Allergy (Q3); Pharmacology (Q3); Toxicology (Q3)"
339;17700155034;Natural product communications;journal;15559475, 1934578X;0.3670000000000001;Q3;35;413;811;9844;746;792;0.96;23,84;United States;Natural Product Communications;2008-ongoing;"Complementary and Alternative Medicine (Q1); Medicine (miscellaneous) (Q2); Plant Science (Q2); Drug Discovery (Q3); Pharmacology (Q3)"
340;4000148204;Pakistan Journal of Pharmaceutical Sciences;journal;1011601X;0.3670000000000001;Q2;35;80;202;2105;275;201;1.26;26,31;Pakistan;University of Karachi;2005-ongoing;Pharmaceutical Science (Q2)
341;18384;Medicinal Chemistry Research;journal;10542523;0.366;Q1;38;106;166;2674;201;165;1.02;25,23;United States;Birkhauser Boston;1994, 1996-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Organic Chemistry (Q3)"
342;25223;Toxicology and Industrial Health;journal;07482337, 14770393;0.363;Q3;52;79;190;2819;247;181;1.19;35,68;United States;SAGE Publications;1985-ongoing;"Public Health, Environmental and Occupational Health (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
343;5400152628;Brazilian Journal of Pharmacognosy;journal;0102695X, 1981528X;0.361;Q1;37;153;326;4814;325;314;0.75;31,46;Brazil;Sociedade Brasileira de Farmacognosia;2007-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)
344;21717;Die Pharmazie;journal;00317144;0.361;Q2;56;167;442;4710;491;438;1.07;28,20;Germany;Govi Verlag Pharmazeutischer Verlag GmbH;1947-ongoing;Pharmaceutical Science (Q2)
345;19700174891;Perspectives in Medicinal Chemistry;journal;1177391X;0.36;Q2;13;3;10;113;15;10;1.5;37,67;New Zealand;Libertas Academica;2008-2011, 2014-ongoing;"Pharmaceutical Science (Q2); Pharmacology (medical) (Q2); Drug Discovery (Q3); Pharmacology (Q3)"
346;4700152608;African Journal of Traditional, Complementary and Alternative Medicines;journal;01896016;0.353;Q3;36;48;128;1114;149;126;0.84;23,21;Nigeria;African Networks on Ethnomedicines;1970, 1973-1978, 1981-1982, 1991, 1995, 2002, 2006-2016 (cancelled);"Complementary and Alternative Medicine (Q1); Medicine (miscellaneous) (Q2); Drug Discovery (Q3)"
347;19700174958;Drug Testing and Analysis;journal;19427611, 19427603;0.35200000000000004;Q2;44;81;78;2301;103;69;1.49;28,41;United Kingdom;John Wiley & Sons Ltd.;2009-ongoing;"Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Environmental Chemistry (Q4); Spectroscopy (Q4)"
348;11200153563;Drug Metabolism Letters;journal;18723128;0.35100000000000003;Q2;23;35;118;727;118;116;1.2;20,77;United Arab Emirates;Bentham Science Publishers;2007-ongoing;"Biochemistry (medical) (Q2); Pharmaceutical Science (Q2); Pharmacology (medical) (Q2); Clinical Biochemistry (Q3)"
349;34545;Journal of Asian Natural Products Research;journal;10286020, 14772213;0.35;Q2;35;159;460;2639;375;459;0.76;16,60;United Kingdom;Taylor & Francis;1998-ongoing;"Complementary and Alternative Medicine (Q1); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Drug Discovery (Q3); Molecular Medicine (Q3); Organic Chemistry (Q3); Pharmacology (Q3)"
350;21246;International Journal of Immunopathology and Pharmacology;journal;03946320;0.348;Q3;45;170;361;3642;707;351;2.33;21,42;Italy;SAGE Publications Inc.;1989-ongoing;"Immunology (Q3); Immunology and Allergy (Q3); Pharmacology (Q3)"
351;4900153304;Archives of Environmental and Occupational Health;journal;19338244;0.345;Q3;58;44;104;1164;99;88;1.18;26,45;United States;Heldref Publications;2005-ongoing;"Environmental Science (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3)"
352;17700156313;Iranian Journal of Pharmaceutical Research;journal;17350328, 17266890;0.345;Q1;31;63;91;1446;76;83;0.92;22,95;Iran;Shaheed Behesti University of Medical Sciences and Health;2008-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacology (medical) (Q2)"
353;130016;Cutaneous and Ocular Toxicology;journal;15569527, 15569535;0.343;Q3;25;52;98;1201;119;95;1.0;23,10;United Kingdom;Taylor & Francis;1982-2000, 2005-ongoing;"Medicine (miscellaneous) (Q2); Toxicology (Q3)"
354;20766;Drug and Chemical Toxicology;journal;01480545, 15256014;0.34;Q3;38;53;117;1796;138;117;1.12;33,89;United States;Marcel Dekker Inc.;1977-ongoing;"Chemical Health and Safety (Q2); Medicine (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q3); Pharmacology (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3)"
355;22456;International Journal of Pharmacy Practice;journal;09617671;0.34;Q2;32;121;151;1682;88;133;0.58;13,90;United Kingdom;Wiley-Blackwell;1991-ongoing;"Pharmacy (Q1); Health Policy (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Public Health, Environmental and Occupational Health (Q3)"
356;19700174913;Therapeutic Advances in Neurological Disorders;journal;17562864, 17562856;0.339;Q3;40;35;52;2179;47;44;1.07;62,26;United Kingdom;SAGE Publications;2008-ongoing;"Neurology (Q3); Neurology (clinical) (Q3); Pharmacology (Q3)"
357;24111;Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry;journal;03764699;0.334;Q2;43;153;471;3854;333;469;0.7;25,19;India;Scientific Publishers;1970, 1973-1978, 1981, 1989-1991, 1996-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Organic Chemistry (Q3)"
358;144963;Drug Discovery Today: Disease Models;journal;17406757;0.33;Q3;23;19;113;746;71;96;0.76;39,26;Netherlands;Elsevier BV;2004-ongoing;"Drug Discovery (Q3); Molecular Medicine (Q3)"
359;110097;Food and Drug Law Journal;journal;1064590X;0.329;Q3;18;35;117;7167;60;117;0.57;204,77;United States;Food and Drug Law Institute;1992-ongoing;"Law (Q2); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Public Health, Environmental and Occupational Health (Q3)"
360;21328;European Journal of Drug Metabolism and Pharmacokinetics;journal;03787966;0.327;Q3;34;11;94;224;67;92;0.48;20,36;France;Springer Paris;1976-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
361;11300153402;Biomarkers in Medicine;journal;17520363, 17520371;0.326;Q3;37;97;98;5641;103;75;1.37;58,15;United Kingdom;Future Medicine Ltd.;2008-ongoing;"Biochemistry (medical) (Q3); Clinical Biochemistry (Q3); Drug Discovery (Q3)"
362;21100218041;Anti-Infective Agents;journal;22113533, 22113525;0.321;Q3;21;18;73;1885;73;70;1.02;104,72;United Arab Emirates;Bentham Science Publishers;2012-ongoing;"Infectious Diseases (Q3); Pharmacology (Q3)"
363;12000154522;Advances in Antiviral Drug Design;book series;10758593;0.32;Q2;11;0;7;0;6;6;0.0;0,00;United States;JAI Press;1996, 1999, 2003, 2007;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Infectious Diseases (Q3); Pharmacology (medical) (Q3); Virology (Q3)"
364;19700174961;BioProcess International;trade journal;15426319;0.319;Q3;20;141;150;737;51;147;0.35;5,23;United States;BioProcess International;2009-ongoing;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Drug Discovery (Q3)"
365;21208;Drug Discovery Today: Therapeutic Strategies;journal;17406773;0.319;Q3;26;12;100;524;71;85;0.86;43,67;Netherlands;Elsevier BV;2004-2014;"Drug Discovery (Q3); Molecular Medicine (Q3); Pharmacology (Q3)"
366;19700180785;Studies in Natural Products Chemistry;book series;15725995;0.318;Q3;33;0;36;0;36;31;1.16;0,00;Netherlands;Elsevier BV;1995-1997, 2000-2003, 2005-2006, 2008, 2012-ongoing;"Drug Discovery (Q3); Organic Chemistry (Q3)"
367;145524;Drug Discovery Today: Disease Mechanisms;journal;17406765;0.317;Q3;22;31;89;1578;77;78;0.95;50,90;Netherlands;Elsevier BV;2004-2014;"Drug Discovery (Q3); Molecular Medicine (Q3)"
368;21082;Pharmaceutical Biology;journal;13880209, 17445116;0.315;Q2;53;228;419;6719;335;409;0.72;29,47;United Kingdom;Taylor & Francis;1961-1972, 1975-ongoing;"Complementary and Alternative Medicine (Q2); Pharmaceutical Science (Q2); Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Molecular Medicine (Q3); Pharmacology (Q3)"
369;17500155003;Records of Natural Products;journal;13076167;0.315;Q3;24;34;25;1052;20;23;0.87;30,94;Turkey;ACG Publications;2009-ongoing;"Drug Discovery (Q3); Organic Chemistry (Q3); Pharmacology (Q3); Plant Science (Q3)"
370;22204;Journal of Drug Delivery Science and Technology;journal;17732247;0.309;Q2;38;57;172;3286;123;169;0.67;57,65;France;Editions de Sante;2004-ongoing;Pharmaceutical Science (Q2)
371;19700175099;Topics in Medicinal Chemistry;book series;18622461;0.306;Q3;8;15;10;1612;7;8;0.88;107,47;Germany;Springer Verlag;2009-ongoing;"Drug Discovery (Q3); Molecular Medicine (Q3)"
372;19700188217;Bioanalysis;journal;17576180, 17576199;0.298;Q2;51;177;127;6234;140;112;1.25;35,22;United Kingdom;Future Medicine Ltd.;2009-ongoing;"Medical Laboratory Technology (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Analytical Chemistry (Q3); Clinical Biochemistry (Q3); Medicine (miscellaneous) (Q3)"
373;22393;Indian Journal of Pharmacology;journal;02537613, 19983751;0.295;Q3;52;121;220;2017;201;178;0.96;16,67;India;Medknow Publications;1978-1980, 1982, 1984-1986, 1994-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
374;11200153306;Journal of Pharmacology and Toxicology;journal;1816496X;0.294;Q2;15;11;66;320;47;66;0.71;29,09;United States;Academic Journals Inc.;2008-2016 (cancelled);Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
375;20710;DARU, Journal of Pharmaceutical Sciences;journal;15608115;0.293;Q3;33;48;127;1092;111;126;0.97;22,75;United Kingdom;BioMed Central;2000-ongoing;"Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
376;130045;Journal of Applied Biomedicine;journal;12140287, 1214021X;0.293;Q2;26;25;64;1133;89;64;1.78;45,32;Spain;Elsevier Espana;2005-ongoing;"Agricultural and Biological Sciences (miscellaneous) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Medicine (miscellaneous) (Q3); Neuroscience (miscellaneous) (Q3)"
377;19700174987;Research Journal of Toxins;journal;18193560;0.293;Q3;2;0;2;0;2;2;1.0;0,00;United States;Academic Journals Inc.;2009, 2014-2016 (cancelled);"Agronomy and Crop Science (Q2); Food Science (Q2); Toxicology (Q3)"
378;19400157146;Food Additives and Contaminants: Part B Surveillance;journal;19393210, 19393229;0.292;Q3;21;39;46;1187;43;45;0.96;30,44;United Kingdom;Taylor & Francis;2008-ongoing;"Food Science (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3)"
379;19700175105;Open Drug Delivery Journal;journal;18741266;0.29100000000000004;Q2;5;8;3;172;4;3;1.33;21,50;United Arab Emirates;Bentham Science Publishers;2009-2010, 2014;Pharmaceutical Science (Q2)
380;20065;BioPharm International;journal;1542166X;0.28800000000000003;Q2;25;99;347;657;110;300;0.38;6,64;United States;UBM Medica Periodical Publication;2002-ongoing;"Pharmaceutical Science (Q2); Biotechnology (Q3)"
381;10900153302;Biomarker Insights;journal;11772719;0.28600000000000003;Q3;24;19;41;621;46;41;1.12;32,68;New Zealand;Libertas Academica;2008-ongoing;"Biochemistry (medical) (Q3); Molecular Medicine (Q3); Pharmacology (Q3)"
382;25144;Journal of Health Science;journal;13475207, 13449702;0.284;Q3;42;92;355;3185;301;351;0.86;34,62;Kenya;African Forum for Health Sciences;1999-2011;"Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
383;73430;Pharmaceutical Technology;journal;15432521;0.284;Q2;35;175;584;628;108;444;0.22;3,59;United States;UBM Medica Periodical Publication;1979-1985, 1987, 1996-ongoing;"Pharmaceutical Science (Q2); Biophysics (Q3)"
384;3900148201;International Journal of Pharmacology;journal;18125700, 18117775;0.28300000000000003;Q3;29;111;220;4329;178;220;0.9;39,00;Pakistan;Asian Network for Scientific Information;2006-ongoing;Pharmacology (Q3)
385;19700174931;Asian Journal of Pharmaceutics;journal;1998409X, 09738398;0.281;Q2;16;47;61;1198;45;55;0.82;25,49;India;Medknow Publications;2009-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
386;17700156434;Current Pharmacogenomics and Personalized Medicine;journal;18756913, 18756921;0.281;Q3;17;32;53;2735;59;47;1.26;85,47;United Arab Emirates;Bentham Science Publishers;2008-ongoing;"Molecular Medicine (Q3); Pharmacology (Q3); Genetics (Q4); Genetics (clinical) (Q4); Molecular Biology (Q4)"
387;21211;Pharmacy Education;journal;14772701, 15602214;0.281;Q2;15;20;67;338;42;67;0.68;16,90;United Kingdom;Taylor & Francis;1973-1978, 2002-ongoing;"Pharmacy (Q1); Pharmaceutical Science (Q2); Education (Q3)"
388;35190;Revista Espanola de Quimioterapia;journal;02143429;0.279;Q3;23;38;138;921;108;123;0.81;24,24;Spain;Sociedad Espaola de Quimioterapia;1989-ongoing;"Medicine (miscellaneous) (Q3); Microbiology (medical) (Q3); Pharmacology (Q3)"
389;20578;Journal of Food and Drug Analysis;journal;10219498;0.278;Q3;41;53;165;1488;140;163;0.71;28,08;Taiwan;Elsevier Taiwan LLC;1994-ongoing;"Food Science (Q3); Pharmacology (Q3)"
390;25241;Toxicology Mechanisms and Methods;journal;15376524, 15376516;0.278;Q3;35;75;217;3336;231;205;1.2;44,48;United Kingdom;Taylor & Francis;1991-ongoing;"Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
391;15340;Developments in Biologicals;book series;14246074;0.277;Q3;35;1;212;0;166;205;1.11;0,00;Switzerland;S. Karger AG;2000-2008, 2010-2013;"Pharmacology (Q3); Biomaterials (Q4); Immunology (Q4)"
392;21100241807;Artificial Cells, Nanomedicine and Biotechnology;journal;2169141X, 21691401;0.275;Q2;35;43;146;1072;116;137;0.71;24,93;United States;Informa Healthcare;2013-ongoing;"Pharmaceutical Science (Q2); Biomedical Engineering (Q3); Biotechnology (Q3); Medicine (miscellaneous) (Q3)"
393;19700175086;Drug, Healthcare and Patient Safety;journal;11791365;0.272;Q3;18;25;10;1393;7;9;0.78;55,72;New Zealand;Dove Medical Press Ltd.;2009-ongoing;"Health Policy (Q3); Pharmacology (Q3)"
394;4700152701;Pharmacy Practice;journal;1885642X, 18863655;0.272;Q2;19;37;89;975;59;89;0.58;26,35;Spain;Centro de Investigaciones y Publicaciones Farmaceuticas;2006-ongoing;"Pharmacy (Q1); Pharmaceutical Science (Q2)"
395;18200156702;World Mycotoxin Journal;journal;18750710, 18750796;0.264;Q3;30;48;49;2652;57;48;1.19;55,25;Netherlands;Wageningen Academic Publishers;2009-ongoing;"Food Science (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3)"
396;20627;Clinical Research and Regulatory Affairs;journal;15322521, 10601333;0.262;Q2;14;17;36;409;15;35;0.44;24,06;United States;Marcel Dekker Inc.;1983-1990, 1992-ongoing;"Pharmaceutical Science (Q2); Pharmacology (Q3); Pharmacology (medical) (Q3)"
397;26653;Journal of Herbal Pharmacotherapy;journal;15229106, 15228940;0.261;Q3;25;0;32;0;33;31;0.0;0,00;United States;The Haworth Herbal Press;2001-2007;"Pharmacology (Q3); Biochemistry (Q4)"
398;19400158813;HIV Therapy;journal;17584329, 17584310;0.26;Q3;12;48;60;4159;25;42;0.6;86,65;United Kingdom;Future Medicine Ltd.;2009-2010;"Dermatology (Q3); Drug Discovery (Q3); Infectious Diseases (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3); Virology (Q4)"
399;25171;Mycotoxin Research;journal;01787888;0.26;Q3;31;34;89;1165;67;80;0.92;34,26;Germany;Springer Verlag;1993-1995, 2008-ongoing;"Biotechnology (Q3); Toxicology (Q3); Microbiology (Q4)"
400;19200156706;Pharmacognosy Magazine;journal;09731296, 09764062;0.26;Q2;29;67;161;1593;108;157;0.69;23,78;India;Medknow Publications;2008-ongoing;"Pharmaceutical Science (Q2); Drug Discovery (Q3)"
401;21811;Farmacia Hospitalaria;journal;11306343;0.259;Q3;21;75;223;1345;128;114;0.91;17,93;Spain;Aran Ediciones SA;1990-ongoing;"Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
402;130089;Toxin Reviews;journal;15569543, 15569551;0.258;Q3;38;12;67;966;69;64;1.12;80,50;United Kingdom;Taylor & Francis;1982-ongoing;Toxicology (Q3)
403;20572;PZ Prisma;journal;09455566;0.257;Q2;5;35;77;588;8;66;0.16;16,80;Germany;Govi Verlag Pharmazeutischer Verlag GmbH;1994-ongoing;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
404;130038;Letters in Drug Design and Discovery;journal;15701808;0.256;Q2;28;114;257;3563;202;256;0.73;31,25;United Arab Emirates;Bentham Science Publishers;2005-ongoing;"Pharmaceutical Science (Q2); Drug Discovery (Q3); Molecular Medicine (Q4)"
405;19700174906;Molecular and Cellular Pharmacology;journal;19381247;0.255;Q2;21;27;32;1156;18;23;0.78;42,81;United States;Lumitext Publishing;2009-ongoing;"Pharmaceutical Science (Q2); Molecular Biology (Q4)"
406;19700177407;Interdisciplinary Toxicology;journal;13379569, 13376853;0.253;Q3;23;27;52;897;41;52;0.79;33,22;Slovakia;Slovak Toxicology Society SETOX;2010-ongoing;"Health, Toxicology and Mutagenesis (Q3); Pharmacology (Q3); Toxicology (Q3)"
407;19700174969;Archives of Drug Information;journal;17535174;0.251;Q2;10;7;24;136;17;23;0.74;19,43;United States;John Wiley & Sons Inc.;2008-2011;"Complementary and Alternative Medicine (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
408;21100470510;Drug Research;journal;21949379, 21949387;0.247;Q3;56;128;364;3189;268;358;0.64;24,91;Germany;Thieme;1972, 2013-ongoing;"Drug Discovery (Q3); Medicine (miscellaneous) (Q3)"
409;10900153328;Frontiers in Drug Design and Discovery;book series;15672042;0.246;Q2;8;0;40;0;33;38;0.56;0,00;United Arab Emirates;Bentham Science Publishers;2006-2009;"Pharmaceutical Science (Q2); Drug Discovery (Q3); Molecular Medicine (Q4)"
410;4700152607;Current Enzyme Inhibition;journal;15734080;0.245;Q3;15;23;65;2088;46;65;0.58;90,78;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Drug Discovery (Q3); Biochemistry (Q4); Molecular Medicine (Q4)"
411;19700175244;Current Radiopharmaceuticals;journal;18744710;0.245;Q3;21;22;32;1723;25;29;0.86;78,32;United Arab Emirates;Bentham Science Publishers;2009-ongoing;"Pharmacology (Q3); Radiology, Nuclear Medicine and Imaging (Q3)"
412;23171;Korean Journal of Pharmacognosy;journal;02533073;0.245;Q2;14;56;197;1178;77;197;0.44;21,04;South Korea;Korean Society of Pharmacognosy;1990-ongoing;"Pharmaceutical Science (Q2); Drug Discovery (Q3); Pharmacology (Q3)"
413;17700156714;Pharmaceuticals;journal;14248247;0.243;Q2;44;185;14;18278;13;13;1.0;98,80;Switzerland;Multidisciplinary Digital Publishing Institute (MDPI);2009-ongoing;"Pharmaceutical Science (Q2); Molecular Medicine (Q4)"
414;23489;Chemical Speciation and Bioavailability;journal;09542299;0.242;Q4;25;30;70;982;50;68;0.61;32,73;United Kingdom;Taylor & Francis;1989-ongoing;"Chemical Health and Safety (Q3); Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
415;3200147837;Journal of Exercise Science and Fitness;journal;1728869X;0.24;Q2;17;17;52;520;24;50;0.47;30,59;Singapore;Elsevier (Singapore) Pte Ltd;2005-ongoing;"Pharmaceutical Science (Q2); Pharmacology (nursing) (Q2); Sports Science (Q3)"
416;19446;American Pharmaceutical Review;journal;10998012;0.238;Q2;20;86;281;1240;113;281;0.47;14,42;United States;Russell Publishing LLC;2002-ongoing;Pharmaceutical Science (Q2)
417;59665;Chinese Journal of Natural Medicines;journal;18755364, 20956975;0.236;Q3;27;48;279;866;135;275;0.56;18,04;China;China Pharmaceutical University;2004-ongoing;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q3); Medicine (miscellaneous) (Q3)"
418;11200153304;Future HIV Therapy;journal;17469600;0.236;Q3;8;0;57;0;34;46;0.74;0,00;United Kingdom;Future Medicine Ltd.;2008-2009;"Drug Discovery (Q3); Infectious Diseases (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3); Virology (Q4)"
419;22881;Yao xue xue bao = Acta pharmaceutica Sinica;journal;05134870;0.236;Q2;29;259;643;5323;382;641;0.65;20,55;China;Nongton Jie;1960, 1962-1966, 1979-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Molecular Medicine (Q4)"
420;22357;IDrugs : the investigational drugs journal;journal;13697056;0.235;Q3;32;178;474;2025;249;472;0.6;11,38;United Kingdom;Current Drugs Ltd.;1998-2010;"Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
421;24097;Journal of the Indian Chemical Society;journal;00194522;0.235;Q3;31;210;628;5508;242;619;0.41;26,23;India;Scientific Publishers;1973-1985, 1987-1991, 1996-ongoing;"Drug Discovery (Q3); Electrochemistry (Q4); Inorganic Chemistry (Q4); Organic Chemistry (Q4); Physical and Theoretical Chemistry (Q4)"
422;4700152769;Pharmacopeial Forum;journal;03634655;0.235;Q3;16;27;48;202;36;47;0.83;7,48;United States;Pharmacopeia;1996-1998, 2000-2017 (cancelled);"Drug Guides (Q2); Pharmacy (Q2); Pharmacology (Q3)"
423;19700182039;International Journal of Green Nanotechnology: Biomedicine;journal;19430868, 1943085X;0.234;Q2;11;5;11;391;13;10;1.3;78,20;United States;Taylor and Francis;2009-2012;"Pharmaceutical Science (Q2); Biomedical Engineering (Q3); Nanoscience and Nanotechnology (Q4)"
424;130072;International Journal of Medicinal Mushrooms;journal;15219437;0.234;Q3;25;44;101;1245;62;100;0.65;28,30;United States;Begell House;2005-ongoing;"Applied Microbiology and Biotechnology (Q3); Pharmacology (Q3); Drug Discovery (Q4)"
425;19700175039;Open Toxicology Journal;journal;18743404;0.229;Q4;5;8;7;209;6;7;0.86;26,13;United Arab Emirates;Bentham Science Publishers;2009-2013;Toxicology (Q4)
426;25425;Journal of Herbs, Spices and Medicinal Plants;journal;15403580, 10496475;0.228;Q3;24;22;85;455;45;85;0.55;20,68;United States;The Haworth Herbal Press;1992-ongoing;"Complementary and Alternative Medicine (Q2); Pharmacology (Q3)"
427;22854;Yakugaku Zasshi;journal;00316903;0.228;Q2;37;235;631;4830;369;596;0.57;20,55;Japan;Pharmaceutical Society of Japan;1961-ongoing;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
428;19200156925;Cancer Therapy;journal;15439143, 15439135;0.227;Q3;8;18;47;668;14;47;0.3;37,11;United States;Gene Therapy Press;2009-2014;"Oncology (Q3); Pharmacology (Q3); Cancer Research (Q4)"
429;19700175149;African Journal Biomedical Research;journal;11195096;0.226;Q2;15;36;48;806;31;47;0.66;22,39;Nigeria;Bioline International;2008, 2010-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Medicine (miscellaneous) (Q3)"
430;5700165173;Journal of Medical Marketing;journal;17457912, 17457904;0.224;Q2;15;39;132;835;47;108;0.45;21,41;United States;SAGE Publications Inc.;2000-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Marketing (Q3); Medicine (miscellaneous) (Q3); Strategy and Management (Q3)"
431;22212;Scientia Pharmaceutica;journal;22180532, 00368709;0.223;Q2;34;51;103;1385;92;103;0.91;27,16;Austria;MDPI AG;1960-1961, 1973-ongoing;Pharmaceutical Science (Q2)
432;21810;Farmacia;journal;00148237;0.22;Q2;19;91;142;1386;133;142;0.94;15,23;Romania;Uniunea Societatilor De Stiinte Medicale;1973-1987, 2008-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
433;23440;Indian Journal of Physiology and Pharmacology;journal;00195499;0.22;Q3;45;53;173;1308;94;141;0.67;24,68;India;All India Institute of Medical Sciences;1959-ongoing;"Pharmacology (Q3); Physiology (Q4); Physiology (medical) (Q4)"
434;21265;Drugs of the Future;journal;03778282;0.218;Q3;40;115;346;7369;194;340;0.53;64,08;Spain;Prous Science;1978-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
435;10300153301;Expert Review of Clinical Pharmacology;journal;17512433;0.218;Q2;32;68;116;5932;86;99;0.87;87,24;United Kingdom;Taylor & Francis;2008-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Medicine (miscellaneous) (Q3); Pharmacology (medical) (Q3)"
436;14500154702;Journal of Cardiovascular Translational Research;journal;19375395, 19375387;0.218;Q2;44;84;133;5176;68;120;0.57;61,62;United States;Springer New York LLC;2008-ongoing;"Pharmaceutical Science (Q2); Cardiology and Cardiovascular Medicine (Q3); Genetics (Q4); Genetics (clinical) (Q4); Molecular Medicine (Q4)"
437;5400152620;American Journal of Pharmacology and Toxicology;journal;15574970, 15574962;0.217;Q2;16;22;61;700;54;61;1.1;31,82;United States;Science Publications;2007-2016 (cancelled);"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
438;22908;Chinese Pharmacological Bulletin;journal;10011978;0.217;Q3;15;425;1137;6484;691;1137;0.69;15,26;China;Publication Centre of Anhui Medical University;1993-ongoing;Pharmacology (Q3)
439;5800179590;Pharmacologyonline;journal;18278620;0.217;Q3;21;303;708;7894;274;707;0.37;26,05;Italy;SILAE;2007-ongoing;"Pharmacology (Q3); Drug Discovery (Q4)"
440;19700175819;Patient Preference and Adherence;journal;1177889X;0.21600000000000005;Q2;37;29;108;1114;77;107;0.82;38,41;New Zealand;Dove Medical Press Ltd;2007-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Health Policy (Q3); Medicine (miscellaneous) (Q3); Social Sciences (miscellaneous) (Q3)"
441;19600156803;Journal of Medicinal Plant Research;journal;19960875;0.215;Q3;47;371;157;12026;135;151;0.89;32,42;Nigeria;Academic Journals;2009-2011;"Complementary and Alternative Medicine (Q2); Pharmaceutical Science (Q3); Pharmacology (Q3); Plant Science (Q3); Drug Discovery (Q4)"
442;4500151530;Personalized Medicine;journal;17410541;0.215;Q3;24;92;195;2879;132;156;0.88;31,29;United Kingdom;Future Medicine Ltd.;2006-ongoing;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
443;4000152107;Journal of Venomous Animals and Toxins Including Tropical Diseases;journal;16789199;0.213;Q4;22;77;147;2021;69;135;0.4;26,25;United Kingdom;BioMed Central;2006-ongoing;"Animal Science and Zoology (Q3); Infectious Diseases (Q3); Parasitology (Q4); Toxicology (Q4)"
444;19405;Acta Poloniae Pharmaceutica;journal;00016837;0.212;Q3;35;109;289;2362;212;281;0.74;21,67;Poland;Polskie Towarzystwo Farmaceutyczne/Polish Pharmaceutical Society;1951-1955, 1961-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
445;18800156730;Biomolecules and Therapeutics;journal;19769148, 20054483;0.212;Q3;26;60;126;2263;66;126;0.52;37,72;South Korea;Korean Society of Applied Pharmacology;2008-ongoing;"Pharmacology (Q3); Biochemistry (Q4); Drug Discovery (Q4); Molecular Medicine (Q4)"
446;79053;Natural Product Sciences;journal;12263907;0.212;Q4;22;50;142;1226;53;142;0.33;24,52;South Korea;Korean Society of Pharmacognosy;1997-ongoing;"Drug Discovery (Q4); Organic Chemistry (Q4)"
447;22375;Indian Drugs;journal;0019462X;0.211;Q3;30;144;471;2372;127;469;0.19;16,47;India;Scientific Publishers;1989-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q3); Drug Discovery (Q4)"
448;21100795043;Journal of Natural Remedies;journal;23203358, 09725547;0.211;Q3;16;25;111;635;49;110;0.47;25,40;India;Natural Remedies Pvt Ltd.;2002-ongoing;Pharmacology (Q3)
449;21102;Pharmaceutical Journal;journal;00316873;0.211;Q3;25;863;3058;639;102;817;0.11;0,74;United Kingdom;Pharmaceutical Press;1945-1949, 1994-2012, 2014-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
450;19500157062;Current Cardiovascular Risk Reports;journal;19329563, 19329520;0.21;Q3;23;66;219;2832;63;211;0.33;42,91;United States;Current Medicine Group;2007-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
451;24605;Arhiv za Higijenu Rada i Toksikologiju;journal;18486312, 00041254;0.209;Q4;26;51;119;2352;102;116;0.88;46,12;Croatia;Institute for Medical Research and Occupational Health;1953-ongoing;"Public Health, Environmental and Occupational Health (Q3); Toxicology (Q4)"
452;58808;Pharmaceutical Care and Research;journal;16712838;0.209;Q3;7;160;370;1365;38;366;0.09;8,53;China;Yao xue fu wu yu yan jiu za zhi she;2004-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q3); Drug Discovery (Q4)"
453;16698;Revista Brasileira de Plantas Medicinais;journal;15160572;0.202;Q3;23;51;194;1778;59;194;0.25;34,86;Brazil;Fundacao do Instituto de Biociencias;1999-ongoing;"Complementary and Alternative Medicine (Q2); Pharmacology (Q3)"
454;21758;Prescrire International;journal;11677422;0.196;Q3;11;192;557;1307;99;460;0.25;6,81;France;Association Mieux Prescrire;1996-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
455;15842;Journal of Applied Research;journal;1537064X;0.195;Q3;18;16;73;415;22;67;0.4;25,94;United States;Therapeutic Solutions LLC;2001-2014;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
456;18800156708;Tropical Journal of Pharmaceutical Research;journal;15965996;0.195;Q3;29;73;66;1382;68;60;1.13;18,93;Nigeria;University of Benin;2009-ongoing;"Pharmaceutical Science (Q3); Pharmacology (medical) (Q3)"
457;22980;Journal of Basic and Clinical Physiology and Pharmacology;journal;21910286, 07926855;0.194;Q3;30;28;72;915;38;72;0.53;32,68;Germany;Walter de Gruyter GmbH;1985-1988, 1990-ongoing;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Drug Discovery (Q4); Physiology (Q4)"
458;21715;Pharmazeutische Industrie;journal;16167074, 0031711X;0.194;Q3;17;224;625;1841;32;598;0.05;8,22;Germany;Editio Cantor Verlag;1960-1961, 1973-ongoing;Pharmaceutical Science (Q3)
459;21207;Drug Discovery Today: Technologies;journal;17406749;0.193;Q4;41;35;50;1374;36;43;0.84;39,26;Netherlands;Elsevier BV;2004-ongoing;"Biotechnology (Q3); Drug Discovery (Q4); Molecular Medicine (Q4)"
460;4000148821;International Journal of Pharmaceutical Compounding;journal;10924221;0.19;Q3;9;146;384;1075;26;348;0.07;7,36;United States;International Journal of Pharmaceutical Compounding (Ijpc);2006-ongoing;"Pharmacology (nursing) (Q2); Pharmacy (Q2); Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3); Pharmacology (medical) (Q3)"
461;21100301409;Issues in Toxicology;book series;17577179;0.19;Q3;12;36;69;2414;31;64;0.68;67,06;United Kingdom;Royal Society of Chemistry;2007-ongoing;"Pharmacology (Q3); Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
462;21142;Pharmaceutisch Weekblad;journal;00316911;0.188;Q3;9;425;1122;640;18;684;0.03;1,51;Netherlands;Royal Netherlands Pharmaceutical Society;1948-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
463;19408;Actualites Pharmaceutiques;journal;05153700;0.187;Q3;5;133;510;308;11;465;0.04;2,32;Netherlands;Elsevier BV;1961, 1963, 1996-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
464;21828;Revista Cubana de Farmacia;journal;00347515, 15612988;0.187;Q3;8;60;119;965;20;112;0.13;16,08;Cuba;Editorial Ciencias Medicas;1980-1991, 1996-2000, 2002, 2004-ongoing;"Pharmacy (Q2); Pharmaceutical Science (Q3); Pharmacology (Q3)"
465;19700188399;Current Protocols in Toxicology;journal;19349254, 19349262;0.18600000000000005;Q4;18;21;64;498;14;51;0.26;23,71;United Kingdom;John Wiley & Sons Ltd.;2001-ongoing;"Medicine (miscellaneous) (Q3); Toxicology (Q4)"
466;23173;Korean Journal of Physiology and Pharmacology;journal;12264512;0.185;Q3;23;64;144;2030;65;144;0.53;31,72;South Korea;Eui-Hak Publishing and Printing Co.;1997-ongoing;"Pharmacology (Q3); Physiology (Q4)"
467;19888;Medical Letter on Drugs and Therapeutics;journal;0025732X;0.185;Q3;18;121;255;441;71;230;0.29;3,64;United States;Medical Letter, Inc.;1965-ongoing;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
468;6400153143;Turkish Journal of Pharmaceutical Sciences;journal;1304530X;0.185;Q3;11;27;57;699;27;56;0.54;25,89;Turkey;Turkish Pharmacists Association;2006-ongoing;"Pharmaceutical Science (Q3); Molecular Medicine (Q4)"
469;19700174905;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;journal;11787007;0.184;Q3;35;14;22;649;15;21;0.71;46,36;New Zealand;Dove Medical Press Ltd.;2009-ongoing;"Internal Medicine (Q3); Pharmacology (Q3)"
470;130031;Journal of Toxicologic Pathology;journal;09149198;0.184;Q4;20;36;75;1159;37;75;0.41;32,19;Japan;Nihon Dokusei Byori Gakkai;1998-2002, 2004-ongoing;"Pathology and Forensic Medicine (Q3); Toxicology (Q4)"
471;19700175040;Open Vaccine Journal;journal;18750354;0.183;Q3;9;24;13;932;12;13;0.92;38,83;United Arab Emirates;Bentham Science Publishers;2009-2013;"Pharmaceutical Science (Q3); Drug Discovery (Q4); Immunology (Q4)"
472;22825;Proceedings of the Western Pharmacology Society;journal;00838969;0.182;Q3;22;13;98;191;49;98;0.28;14,69;United States;Western Pharmacology Society, Inc.;1960-1969, 1973-2011;Pharmacology (Q3)
473;20564;Ceska a Slovenska Farmacie;journal;12107816, 18054439;0.181;Q3;15;36;124;802;45;119;0.34;22,28;Czech Republic;Nakladatelske Stredisko CLSJE Purkyne;1994-ongoing;Pharmaceutical Science (Q3)
474;17700156431;Handbook of Analytical Separations;book series;15677192;0.181;Q2;11;0;32;0;7;0;0.0;0,00;Netherlands;Elsevier BV;2000-2001, 2003-2004, 2007;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pathology and Forensic Medicine (Q3); Analytical Chemistry (Q4); Environmental Chemistry (Q4)"
475;19700182901;Brazilian Journal of Pharmaceutical Sciences;journal;19848250, 21759790;0.18;Q2;32;94;255;2905;101;245;0.31;30,90;Brazil;Universidade de Sao Paulo;2009-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
476;20684;Current Pharmacogenomics;journal;15701603;0.18;Q3;11;0;27;0;17;27;0.0;0,00;United Arab Emirates;Bentham Science Publishers;2004-2007;"Pharmacology (Q3); Genetics (Q4)"
477;4600151506;Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry;journal;18715222;0.17800000000000002;Q3;14;18;97;1632;35;88;0.35;90,67;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Endocrinology, Diabetes and Metabolism (Q3); Pharmacology (Q3); Immunology and Allergy (Q4)"
478;19200156945;Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromaticas;journal;07177917;0.177;Q3;16;66;110;1715;34;97;0.35;25,98;Chile;Universidad de Santiago de Chile;2008-ongoing;"Complementary and Alternative Medicine (Q3); Pharmacology (Q3); Drug Discovery (Q4); Plant Science (Q4)"
479;21100198011;Current Protocols in Pharmacology;journal;19348282, 19348290;0.177;Q3;22;17;53;475;16;49;0.44;27,94;United States;John Wiley and Sons Inc.;2001-ongoing;"Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
480;21100791826;Journal of Traditional Medicines;journal;18813747, 18801447;0.177;Q4;9;24;87;620;19;87;0.19;25,83;Japan;Medical and Pharmaceutical Society for WAKAN-YAKU;2004, 2006-2007;"Complementary and Alternative Medicine (Q3); Drug Discovery (Q4)"
481;13718;Pharmaceutical Engineering;journal;02738139;0.177;Q3;13;41;142;249;18;127;0.12;6,07;United States;International Society for Pharmaceutical Engineering, Inc.;1996-ongoing;Pharmaceutical Science (Q3)
482;19600161802;International Journal of Computational Biology and Drug Design;journal;17560764, 17560756;0.17600000000000002;Q4;12;25;55;748;22;55;0.4;29,92;United Kingdom;Inderscience Enterprises;2008-ongoing;"Computer Science Applications (Q4); Drug Discovery (Q4)"
483;22205;Saudi Pharmaceutical Journal;journal;13190164;0.17600000000000002;Q3;36;31;98;1495;38;96;0.32;48,23;Saudi Arabia;King Saud University;1996-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
484;145096;Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology;journal;14198711;0.175;Q2;14;27;78;791;28;68;0.45;29,30;Hungary;Neuroline;2004-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Neurology (clinical) (Q3); Neuropsychology and Physiological Psychology (Q4); Neuroscience (miscellaneous) (Q4)"
485;19500156813;Procedia in Vaccinology;journal;1877282X;0.175;Q3;10;35;32;724;14;32;0.44;20,69;Netherlands;Elsevier BV;2009-2012;"Pharmaceutical Science (Q3); Drug Discovery (Q4); Immunology (Q4); Infectious Diseases (Q4)"
486;19700175124;Open Neuropsychopharmacology Journal;journal;18765238;0.173;Q3;5;1;12;203;4;11;0.36;203,00;United Arab Emirates;Bentham Science Publishers;2009-2012;"Pharmacology (Q3); Pharmacology (medical) (Q3); Psychiatry and Mental Health (Q3)"
487;17600155051;Drug Delivery Technology;trade journal;15372898;0.172;Q3;9;103;64;728;11;59;0.19;7,07;United States;Drug Delivery Technology, LLC;2009-ongoing;Pharmaceutical Science (Q3)
488;19700177006;Psychopharm Review;trade journal;19369255;0.172;Q3;4;12;12;554;2;12;0.17;46,17;United States;Lippincott Williams & Wilkins Ltd.;2009-2014;"Pharmacology (Q3); Pharmacology (medical) (Q3); Psychiatry and Mental Health (Q3)"
489;5800173394;Current Drug Therapy;journal;15748855;0.171;Q2;14;37;77;2475;50;74;0.67;66,89;United Arab Emirates;Bentham Science Publishers;2007-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
490;12328;Current Therapeutic Research - Clinical and Experimental;journal;0011393X;0.171;Q3;34;28;115;815;48;111;0.53;29,11;United States;Elsevier Inc.;1959-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
491;19700188352;Toxins;journal;20726651;0.171;Q4;56;153;16;14073;10;15;0.67;91,98;Switzerland;Multidisciplinary Digital Publishing Institute (MDPI);2010-ongoing;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
492;5200152602;Acta Pharmaceutica Sciencia;journal;13072080;0.16899999999999998;Q3;15;56;43;1148;12;43;0.29;20,50;Turkey;Istanbul Medipol University;2006-2011, 2016-ongoing;Pharmaceutical Science (Q3)
493;19700174810;International Journal of Pharmacy and Pharmaceutical Sciences;journal;09751491;0.16899999999999998;Q3;37;312;77;6694;44;77;0.57;21,46;India;International Journal of Pharmacy and Pharmaceutical Sciences;2009-2016 (cancelled);"Pharmaceutical Science (Q3); Pharmacology (Q3)"
494;11100153311;Iranian Journal of Pharmacology and Therapeutics;journal;17352657;0.16899999999999998;Q3;18;20;85;564;36;85;0.15;28,20;Iran;Razi Institute for Drug Research of IUMS;2006-2015;Pharmacology (Q3)
495;19700174900;International Journal of Green Pharmacy;journal;19984103, 09738258;0.168;Q3;18;55;68;1552;39;64;0.61;28,22;India;Medknow Publications;2009-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
496;21718;Pharmazie in Unserer Zeit;journal;00483664, 16151003;0.168;Q3;12;79;220;787;39;190;0.21;9,96;United Kingdom;John Wiley & Sons Ltd.;1972-2012;"Pharmaceutical Science (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
497;19700170617;EXCLI Journal;journal;16112156;0.16699999999999998;Q3;24;20;28;630;17;27;0.63;31,50;Germany;University of Mainz;2009-ongoing;"Pharmacology (Q3); Animal Science and Zoology (Q4); Drug Discovery (Q4); Molecular Medicine (Q4)"
498;19700171017;African Journal of Pharmacy and Pharmacology;journal;19960816;0.166;Q3;25;126;102;3676;53;102;0.52;29,17;Nigeria;Academic Journals;2009-2011;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
499;19400157518;Rasayan Journal of Chemistry;journal;09760083, 09741496;0.166;Q3;18;127;297;2389;95;297;0.32;18,81;India;Rasayan Journal;2009-ongoing;"Chemical Engineering (miscellaneous) (Q3); Chemistry (miscellaneous) (Q3); Energy (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biochemistry (Q4)"
500;73076;Drug Discovery World;journal;14694344;0.16399999999999998;Q4;10;59;119;457;41;108;0.45;7,75;United Kingdom;R J Communications & Media World Ltd.;2004-ongoing;Drug Discovery (Q4)
501;21292;Epitheorese Klinikes Farmakologias kai Farmakokinetikes;journal;10116575;0.16399999999999998;Q3;4;39;151;1133;10;148;0.06;29,05;Bulgaria;Pharmakon Press;1989-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
502;19200156909;Indian Journal of Pharmaceutical Education and Research;journal;00195464;0.16399999999999998;Q3;17;52;127;939;45;120;0.38;18,06;India;Association of Pharmaceutical Teachers of India;2008-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
503;21083;Pharmaceutical Care Espana;journal;11396202;0.16399999999999998;Q3;9;20;80;303;11;65;0.18;15,15;Spain;Fundacion Pharamaceutical Care Espana;2001-2016 (cancelled);"Pharmacy (Q2); Pharmaceutical Science (Q3); Pharmacology (Q3)"
504;19381;Acta Farmaceutica Bonaerense;journal;03262383;0.163;Q3;21;0;0;0;0;0;0.0;0,00;Argentina;Colegio de Farmaceuticos de la Provincia de Buenos Aires;1989-2006;"Pharmaceutical Science (Q3); Drug Discovery (Q4)"
505;145693;Canadian Pharmacists Journal;journal;17151635;0.163;Q3;18;112;286;884;35;178;0.25;7,89;Canada;Canadian Pharmacists Association;2005-ongoing;"Pharmacy (Q2); Pharmaceutical Science (Q3)"
506;19700175071;Open Bioactive Compounds Journal;journal;18748473;0.163;Q3;5;3;3;134;4;3;1.33;44,67;United Arab Emirates;Bentham Science Publishers;2009-2010, 2013;"Pharmaceutical Science (Q3); Pharmacology (Q3); Biochemistry (Q4); Drug Discovery (Q4); Molecular Biology (Q4); Molecular Medicine (Q4)"
507;19461;Annales Pharmaceutiques Francaises;journal;00034509;0.161;Q3;22;40;123;1723;58;113;0.62;43,08;France;Elsevier Masson;1946-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
508;19700175060;International Journal of PharmTech Research;journal;24559563, 09744304;0.161;Q3;40;389;275;8489;135;275;0.49;21,82;India;Sphinx Knowledge House;2009-2016 (cancelled);"Pharmaceutical Science (Q3); Pharmacology (Q3)"
509;23074;Journal of Pharmaceutical Finance, Economics and Policy;journal;15385396, 15385698;0.16;Q3;7;0;35;0;5;27;0.16;0,00;United States;Haworth Press Inc.;2003-2008;"Pharmaceutical Science (Q3); Health Policy (Q4); Pharmacology (Q4)"
510;21100226424;Toxicology and Environmental Health Sciences;journal;20059752;0.16;Q4;12;39;30;1167;7;30;0.23;29,92;South Korea;Korean Society of Environmental Risk Assessment and Health Science;2009-ongoing;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
511;20599;Paediatric and Perinatal Drug Therapy;journal;14630095;0.159;Q4;17;0;31;0;17;26;0.38;0,00;United Kingdom;Librapharm Ltd.;1997-2008;"Pediatrics, Perinatology and Child Health (Q3); Pharmacology (Q4)"
512;17700156705;Modern Trends in Pharmacopsychiatry;book series;16622685;0.157;Q4;10;15;10;1336;6;9;0.67;89,07;Switzerland;Karger;2009-2010, 2013-ongoing;"Medicine (miscellaneous) (Q3); Psychiatry and Mental Health (Q3); Pharmacology (Q4)"
513;50105;Japanese Journal of Neuropsychopharmacology;journal;13434144;0.156;Q4;9;32;78;746;25;78;0.31;23,31;Japan;Nihon Shinkei Seishin Yakuri Gakkai/Japanese Society of Neuropsychophamacology;1982-1997, 2002-ongoing;"Pharmacology (medical) (Q3); Clinical Psychology (Q4); Pharmacology (Q4); Psychiatry and Mental Health (Q4)"
514;22937;Zhongguo Zhongyao Zazhi;journal;10015302;0.156;Q3;26;732;1746;8949;430;1746;0.21;12,23;China;Zhongguo Zhongyi Yanjiuyuan;1989-ongoing;"Complementary and Alternative Medicine (Q3); Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
515;9800153137;Trastornos Adictivos;journal;15750973;0.155;Q4;8;24;93;501;24;67;0.27;20,88;Spain;Elsevier Doyma;2007-2012;"Pharmacology (Q4); Psychiatry and Mental Health (Q4)"
516;19700170837;Vitae;journal;01214004;0.155;Q3;11;27;40;730;8;38;0.21;27,04;Colombia;Universidad de Antioquia;2009-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Applied Microbiology and Biotechnology (Q4); Bioengineering (Q4); Biotechnology (Q4); Food Science (Q4)"
517;19600162009;Advances in Molecular Toxicology;book series;18720854;0.153;Q4;10;8;15;1244;5;13;0.38;155,50;Netherlands;Elsevier BV;2006, 2008-ongoing;"Health, Toxicology and Mutagenesis (Q4); Pharmacology (Q4); Toxicology (Q4)"
518;22934;Chinese Pharmaceutical Journal;journal;10012494;0.153;Q3;19;497;1358;6253;216;1358;0.14;12,58;China;Zhonogguo Yaoxuehui;1993-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
519;5900153315;Pharmacoeconomics - Spanish Research Articles;journal;1695405X;0.151;Q3;5;16;45;458;14;40;0.22;28,63;Switzerland;Springer International Publishing AG;2007-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Health Policy (Q4)"
520;19399;Acta Pharmaceutica Hungarica;journal;00016659;0.15;Q3;12;16;65;649;12;65;0.17;40,56;Hungary;Magyar Gyogyszereszeti Tarsasag/Hungarian Pharmaceutical Association;1965-ongoing;"Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3)"
521;11900154394;Oriental Journal of Chemistry;journal;0970020X, 22315039;0.15;Q4;18;267;399;5365;73;399;0.18;20,09;India;Scientific Publishers;2008-ongoing;"Chemistry (miscellaneous) (Q3); Biochemistry (Q4); Drug Discovery (Q4); Environmental Chemistry (Q4)"
522;6800153106;International Journal of Essential Oil Therapeutics;journal;19614209;0.149;Q3;10;14;90;362;26;89;0.25;25,86;France;Essential Oil Resource Consultants;2007-2010;"Complementary and Alternative Medicine (Q3); Pharmaceutical Science (Q3); Pharmacology (medical) (Q3)"
523;23107;Journal of Pharmacy Technology;journal;87551225;0.149;Q3;9;35;85;752;18;82;0.14;21,49;United States;SAGE Publications Inc.;1989-ongoing;Pharmaceutical Science (Q3)
524;4600151507;Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry;journal;18715230;0.14800000000000002;Q4;19;37;95;3601;30;85;0.28;97,32;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Medicine (miscellaneous) (Q3); Immunology (Q4); Immunology and Allergy (Q4); Pharmacology (Q4)"
525;19459;Ankara Universitesi Eczacilik Fakultesi Dergisi;journal;10153918;0.147;Q3;9;17;63;555;16;63;0.13;32,65;Turkey;Ankara Universitesi;1997-2001, 2003-2010, 2014, 2016-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
526;19700174893;Dhaka University Journal of Pharmaceutical Sciences;journal;18161839, 18161820;0.147;Q3;10;21;87;368;21;87;0.23;17,52;Bangladesh;University of Dhaka;2007-ongoing;"Pharmaceutical Science (Q3); Pharmacology (medical) (Q3)"
527;12100156823;5th PCIC Europe 2008: Petroleum and Chemical Industry Conference Europe;conference and proceedings;00002008;0.146;-;5;0;29;0;8;28;0.29;0,00;United States;;2008;"Chemical Engineering (miscellaneous); Electrical and Electronic Engineering; Geochemistry and Petrology; Pharmaceutical Science"
528;21100304895;Archives of Clinical Infectious Diseases;journal;23452641;0.146;Q4;10;48;45;1123;7;41;0.17;23,40;Iran;Shahid Beheshti University of Medical Sciences;2012-ongoing;"Cardiology and Cardiovascular Medicine (Q3); Critical Care and Intensive Care Medicine (Q3); Infectious Diseases (Q4); Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
529;21412;Zeitschrift fr Phytotherapie : offizielles Organ der Ges. f. Phytotherapie e.V;journal;0722348X;0.145;Q4;12;69;192;803;30;121;0.21;11,64;Germany;Hippokrates Verlag;1982, 1985-ongoing;"Complementary and Alternative Medicine (Q3); Pharmacology (Q4)"
530;25253;Blutalkohol;journal;00065250;0.14400000000000002;Q4;13;40;83;866;11;80;0.12;21,65;Germany;Springer Verlag;1974-2017 (cancelled);"Medicine (miscellaneous) (Q3); Toxicology (Q4)"
531;21100463829;Chinese Journal of Population Resources and Environment;journal;23254262, 10042857;0.14400000000000002;Q4;9;52;165;1003;19;164;0.08;19,29;United Kingdom;Taylor and Francis Ltd.;2015-ongoing;"Demography (Q3); Environmental Science (miscellaneous) (Q3); Toxicology (Q4)"
532;19700175143;Pharmacognosy Reviews;journal;09737847, 09762787;0.14400000000000002;Q4;36;29;41;1603;10;41;0.24;55,28;India;Medknow Publications;2009-ongoing;"Complementary and Alternative Medicine (Q3); Drug Discovery (Q4); Pharmacology (Q4); Plant Science (Q4)"
533;4700152283;Revista de Ciencias Farmaceuticas Basica e Aplicada;journal;18084532;0.14400000000000002;Q3;14;32;127;880;30;126;0.1;27,50;Brazil;Universidade Estadual Paulista (UNESP);2005-ongoing;Pharmaceutical Science (Q3)
534;22858;Japanese Pharmacology and Therapeutics;journal;03863603;0.14300000000000002;Q4;13;98;299;1569;59;298;0.18;16,01;Japan;Life Science Publishing Co. Ltd.;1981-ongoing;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
535;21795;Farmaceuticky Obzor;journal;00148172;0.142;Q3;7;29;97;415;6;93;0.03;14,31;Slovakia;Ministerstvo Zdravotnictva;1961-1963, 1974, 1976-2016 (cancelled);Pharmaceutical Science (Q3)
536;22338;Hospital Pharmacy;journal;00185787;0.141;Q4;21;157;392;1744;65;333;0.14;11,11;United States;Thomas Land Publishers Inc.;1973-ongoing;"Pharmacology (medical) (Q3); Pharmacy (Q3); Pharmacology (Q4)"
537;22514;Japanese Journal of Chemotherapy;journal;13407007;0.141;Q4;12;33;133;579;15;133;0.1;17,55;Japan;Nihon Kagaku Ryoho Gakkai/Japan Society of Chemotherapy;1995-ongoing;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
538;5100152903;Revista Cubana de Plantas Medicinales;journal;10284796;0.141;Q4;11;33;74;561;5;65;0.04;17,00;Cuba;Editorial Ciencias Medicas;1996-1997, 1999-2002, 2005-ongoing;"Drug Discovery (Q4); Pharmacology (Q4); Plant Science (Q4)"
539;21127;Pharmaceutical Technology Europe;journal;17537967;0.14;Q3;16;144;288;429;33;233;0.13;2,98;United States;Advanstar Communications Inc.;1998-ongoing;Pharmaceutical Science (Q3)
540;19978;Ars Pharmaceutica;journal;00042927, 23409894;0.139;Q3;18;192;78;2256;21;78;0.2;11,75;Spain;Editorial Universidad de Granada;1980-1981, 1983-1984, 1986-2001, 2003-2017 (cancelled);"History and Philosophy of Science (Q3); Pharmaceutical Science (Q3)"
541;4000151703;Core Evidence;journal;15551741, 1555175X;0.139;Q4;19;10;49;442;14;48;0.34;44,20;United States;Core Medical Pub;2005-ongoing;"Reviews and References (medical) (Q1); Medicine (miscellaneous) (Q3); Pharmacology (Q4)"
542;19700174971;Indian Journal of Forensic Medicine and Toxicology;journal;09739122, 09739130;0.138;Q4;18;93;130;1286;11;128;0.1;13,83;India;Aall India Institute of Medical Sciences;2008-ongoing;"Law (Q3); Health, Toxicology and Mutagenesis (Q4); Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
543;10600153336;Innovations in Pharmaceutical Technology;trade journal;14717204;0.138;Q3;6;64;179;271;16;172;0.13;4,23;United Kingdom;Samedan Pharmaceutical Publishers Ltd.;2007-2010, 2012-ongoing;Pharmaceutical Science (Q3)
544;19700174933;Journal of Pharmaceutical Sciences and Research;journal;09751459;0.138;Q3;20;125;66;2710;19;66;0.29;21,68;India;PharmaInfo Publications;2009-ongoing;Pharmaceutical Science (Q3)
545;17700156303;Neuromethods;book series;19406045, 08932336;0.138;Q3;17;76;64;4822;10;58;0.17;63,45;United States;Humana Press, Inc.;2009-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Neuroscience (miscellaneous) (Q4); Psychiatry and Mental Health (Q4)"
546;19900191564;Journal of International Peacekeeping;journal;18754104, 18754112;0.13699999999999998;Q4;8;18;12;1393;2;11;0.18;77,39;Netherlands;Brill;1995, 1997, 2001, 2006, 2013-ongoing;"Pharmacology (medical) (Q3); Infectious Diseases (Q4); Pharmacology (Q4); Virology (Q4)"
547;4000151610;International Journal of Neuroprotection and Neurogeneration;journal;17451183, 17451191;0.136;Q4;5;0;29;0;4;24;0.22;0,00;United Kingdom;RPA Publishers.;2006-2008;"Neurology (clinical) (Q4); Pharmacology (Q4)"
548;22906;Journal of China Pharmaceutical University;journal;10005048;0.136;Q3;13;107;304;1776;50;303;0.13;16,60;China;China Pharmaceutical University;1989-1991, 2002-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
549;144613;Journal of Generic Medicines;journal;17411343;0.136;Q3;14;45;115;839;23;106;0.25;18,64;United Kingdom;SAGE Publications Inc.;2003-2017 (cancelled), 2017-2017 (cancelled);Pharmaceutical Science (Q3)
550;80593;Journal of Medicinal Plants;journal;16840240;0.136;Q4;16;90;160;2641;28;160;0.15;29,34;Iran;Pizhuhishkadh-i giyahan-i darayiva faravardah ha-vi tabbii;2004-ongoing;"Complementary and Alternative Medicine (Q3); Pharmacology (Q4)"
551;19700189100;Pharmaceutical Medicine;journal;11782595, 14735679;0.136;Q4;15;35;126;691;39;99;0.45;19,74;United Kingdom;Adis International Ltd.;2008-ongoing;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
552;5100152606;Biosciences Biotechnology Research Asia;journal;09731245, 24562602;0.135;Q4;13;153;449;3005;34;449;0.06;19,64;India;Oriental Scientific Pub. Co.;2005-2016 (cancelled);"Agronomy and Crop Science (Q4); Biotechnology (Q4); Drug Discovery (Q4)"
553;21907;Journal of Anaesthesiology Clinical Pharmacology;journal;09709185;0.135;Q3;25;191;332;2352;40;227;0.16;12,31;India;Medknow Publications;1996-1999, 2002-ongoing;"Anesthesiology and Pain Medicine (Q3); Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
554;21086;Pharmaceutical Chemistry Journal;journal;15739031, 0091150X;0.135;Q4;26;123;477;1973;85;472;0.14;16,04;United States;Kluwer Academic/Plenum Publishers;1967-1977, 1979-1994, 1996-ongoing;"Drug Discovery (Q4); Pharmacology (Q4)"
555;19700175096;Pharmacognosy Journal;journal;09753575;0.135;Q4;14;139;40;2878;17;40;0.43;20,71;India;Pharmacognosy Network Worldwide;2009-ongoing;"Drug Discovery (Q4); Pharmacology (Q4)"
556;19700174904;Asian Journal of Pharmaceutical and Clinical Research;journal;09742441, 24553891;0.133;Q4;26;84;59;1807;22;59;0.37;21,51;India;Asian Journal of Pharmaceutical and Clinical Research;2009-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
557;21800;Farmacevtski Vestnik;journal;00148229;0.133;Q3;4;52;130;1244;12;122;0.1;23,92;Slovenia;Slovensko Farmacevtsko Drustvo;1961, 1989-2016 (cancelled);"Pharmaceutical Science (Q3); Pharmacology (Q4)"
558;19700182122;Pharmaceuticals Policy and Law;journal;2210495X, 13892827;0.133;Q3;9;56;98;484;15;93;0.11;8,64;Netherlands;IOS Press;2010-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Health Policy (Q4)"
559;17300154738;Current Trends in Biotechnology and Pharmacy;journal;09738916;0.132;Q4;10;49;37;1768;12;37;0.32;36,08;India;Association of Biotechnology and Pharmacy;2009-ongoing;"Biotechnology (Q4); Drug Discovery (Q4); Pharmaceutical Science (Q4)"
560;25110;International Journal of Medical Toxicology and Legal Medicine;journal;09720448;0.132;Q4;8;45;78;789;4;78;0.04;17,53;India;All India Institute of Medical Sciences;1999-2003, 2005-2011, 2017-ongoing;"Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
561;15500154707;International Journal of Biological Chemistry;journal;1819155X;0.131;Q4;12;7;17;231;6;17;0.35;33,00;Pakistan;ANSInet;2009-2016 (cancelled);"Biochemistry (Q4); Pharmacology (Q4)"
562;19700175061;Open Pharmacology Journal;journal;18741436;0.131;Q4;6;4;5;400;2;5;0.4;100,00;United Arab Emirates;Bentham Science Publishers;2009-2013;"Drug Discovery (Q4); Molecular Medicine (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
563;16893;Biogenic Amines;journal;15693910, 01688561;0.13;Q4;14;0;31;0;3;31;0.0;0,00;Netherlands;V S P;1989-2007;"Neuroscience (miscellaneous) (Q4); Pharmacology (Q4)"
564;22977;Journal de Pharmacie de Belgique;journal;00472166;0.13;Q4;12;32;64;321;5;59;0.1;10,03;Belgium;Algemene Pharmaceutische Bond;1946-2015;"Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
565;4900152705;NATO Security through Science Series A: Chemistry and Biology;book series;18714641;0.13;Q3;12;0;174;0;49;173;0.42;0,00;Germany;Springer Verlag;2006-2008;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biotechnology (Q4); Chemistry (miscellaneous) (Q4)"
566;21100239829;Current Issues in Pharmacy and Medical Sciences;journal;2084980X, 23006676;0.129;Q4;7;127;101;1891;10;101;0.09;14,89;Poland;Uniwersytet Medyczny w Lublinie;2012-ongoing;"Biochemistry (Q4); Medicine (miscellaneous) (Q4); Molecular Biology (Q4); Pharmacology (Q4)"
567;70864;Anales de la Real Academia Nacional de Farmacia;journal;1697428X, 16974271;0.128;Q4;8;24;97;794;16;95;0.18;33,08;Spain;Real Academia Nacional de Farmacia;2004-2005;"Cell Biology (Q4); Molecular Biology (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
568;130170;Phytotherapie;journal;17652847, 16248597;0.128;Q4;12;71;173;1672;25;123;0.18;23,55;Germany;Springer Verlag;2005-ongoing;"Complementary and Alternative Medicine (Q3); Pharmacology (Q4)"
569;19700175006;Thai Journal of Pharmaceutical Sciences;journal;01254685;0.128;Q4;11;14;12;468;3;12;0.25;33,43;Thailand;Chulalongkorn University;2009-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
570;9100153105;Current Topics in Pharmacology;journal;09724559;0.127;Q4;4;11;49;572;5;49;0.06;52,00;India;Research Trends;2006-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
571;19700174970;Hacettepe University Journal of the Faculty of Pharmacy;journal;13000608;0.127;Q3;6;12;25;498;6;25;0.24;41,50;Turkey;Hacettepe Universitesi;2008-2011;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
572;21716;Pharmazeutische Zeitung;journal;00317136;0.127;Q4;7;516;1315;937;14;583;0.03;1,82;Germany;Govi Verlag Pharmazeutischer Verlag GmbH;1947-1948, 1985-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
573;19700175002;Pharmaceutical Reviews;journal;19185561;0.126;Q4;4;19;32;566;8;32;0.25;29,79;India;PharmaInfo Publications;2009-2011;"Analytical Chemistry (Q4); Drug Discovery (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
574;19700175029;Pharmacogenomics and Personalized Medicine;journal;11787066;0.126;Q4;22;11;9;1260;3;9;0.33;114,55;New Zealand;Dove Medical Press Ltd;2009-ongoing;"Molecular Medicine (Q4); Pharmacology (Q4)"
575;19700175034;Pharmaceutical Processing;trade journal;10499156;0.125;Q3;2;50;58;78;5;47;0.11;1,56;United States;Advantage Business Media;2009-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
576;4000148308;Chinese Traditional and Herbal Drugs;journal;02532670;0.124;Q4;13;304;855;5188;119;855;0.12;17,07;China;Chung Tsao Yao Tsa Chih Pien Chi Pu;2006-ongoing;"Complementary and Alternative Medicine (Q3); Drug Discovery (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
577;22979;Journal of Applied Therapeutic Research;journal;10292659;0.124;Q4;7;8;26;169;5;26;0.14;21,13;United Kingdom;Euromed Communications;1998-2000, 2003-2012;Pharmacology (Q4)
578;21797;Farmaceutisch Tijdschrift voor Belgie;journal;07712367;0.123;Q4;3;20;62;311;3;59;0.07;15,55;Belgium;Algemene Pharmaceutische Bond;1978-2013;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
579;19700174926;International Journal of Health Research;journal;15969819, 15969886;0.122;Q4;7;28;33;797;10;31;0.32;28,46;Nigeria;Poracom Academic Publishers;2009-2012;"Medicine (miscellaneous) (Q4); Pharmacology (Q4)"
580;19700175098;Klinicka Farmakologie a Farmacie;journal;12127973, 18035353;0.122;Q4;4;46;38;1116;3;33;0.09;24,26;Czech Republic;SOLEN s.r.o.;2009-ongoing;"Pharmacy (Q3); Pharmaceutical Science (Q4); Pharmacology (Q4)"
581;21279;Eksperimental'naya i Klinicheskaya Farmakologiya;journal;08692092;0.121;Q4;13;133;236;2095;39;236;0.16;15,75;Russian Federation;Izdatel'stvo Meditsina Publishers;1992-ongoing;"Medicine (miscellaneous) (Q4); Pharmacology (Q4); Toxicology (Q4)"
582;21100804474;European Pharmaceutical Journal;journal;24536725;0.121;Q3;5;12;21;336;4;19;0.21;28,00;Germany;de Gruyter;2016-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
583;18098;Japanese Journal of Psychopharmacology;journal;13402544;0.121;Q4;11;2;1;0;0;1;0.0;0,00;Japan;Nihon Shinkei Seishin Yakuri Gakkai/Japanese Society of Neuropsychophamacology;1981-2017;"Clinical Psychology (Q4); Medicine (miscellaneous) (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
584;19700175004;Open Medicinal Chemistry Journal;journal;18741045;0.121;Q4;15;6;1;539;0;1;0.0;89,83;United Arab Emirates;Bentham Science Publishers;2009-ongoing;"Drug Discovery (Q4); Molecular Medicine (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
585;144879;Toxicology International;journal;09716580;0.121;Q4;21;23;57;485;9;57;0.13;21,09;India;Society of Toxicology;2005-ongoing;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
586;19700174925;European Pharmaceutical Review;trade journal;13608606;0.12;Q3;7;43;29;799;4;23;0.17;18,58;United Kingdom;Russell Publishing Ltd;2009-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biochemistry (Q4); Biophysics (Q4); Biotechnology (Q4); Molecular Medicine (Q4)"
587;25247;Chinese Journal of Pharmacology and Toxicology;journal;10003002;0.119;Q4;11;92;203;1721;26;203;0.16;18,71;China;Chung-Kuo Yao Li Hseuh Hui;1986-ongoing;"Pharmacology (Q4); Toxicology (Q4)"
588;19500157042;Currents in Pharmacy Teaching and Learning;journal;18771297;0.119;Q3;14;34;18;720;2;16;0.13;21,18;Netherlands;Elsevier BV;2009-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Pharmacy (Q3)"
589;11100153314;Frontiers in Medicinal Chemistry;book series;15740889;0.119;Q4;6;15;29;2233;3;28;0.11;148,87;United Arab Emirates;Bentham Science Publishers;2006, 2009-2010;"Drug Discovery (Q4); Molecular Medicine (Q4); Organic Chemistry (Q4)"
590;10300153375;Taiwan Pharmaceutical Journal;journal;10161015;0.119;Q4;5;0;30;0;3;30;0.0;0,00;Taiwan;Pharmaceutical Society of Taiwan;2007, 2009;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
591;145689;Alimentary Pharmacology and Therapeutics Symposium Series;journal;17466334;0.118;Q3;9;0;5;0;0;5;0.0;0,00;United Kingdom;Blackwell Publishing Inc.;2005-2007;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Pharmacology (medical) (Q4)"
592;19700175125;Internet Journal of Pharmacology;journal;15312976;0.118;Q4;7;24;41;652;10;41;0.24;27,17;United States;Internet Scientific Publications;2009-2011;Pharmacology (Q4)
593;19700174940;SA Pharmaceutical Journal;journal;10151362;0.118;Q4;6;165;137;1364;7;100;0.07;8,27;South Africa;Medpharm Publications Ltd.;2009-ongoing;Pharmaceutical Science (Q4)
594;19700175108;Drug Delivery System;journal;09135006;0.117;Q4;7;30;87;698;8;87;0.05;23,27;Japan;Japan Society of Drug Delivery System;2009-ongoing;Pharmaceutical Science (Q4)
595;19200156912;EJHP Practice;journal;20303769, 17819989;0.117;Q3;5;73;148;718;13;102;0.13;9,84;Belgium;Pharma Publishing and Media Europe;2008-2011;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
596;21374;Fabad Journal of Pharmaceutical Sciences;journal;13004182;0.116;Q4;14;24;72;825;4;72;0.02;34,38;Turkey;Society of Pharmaceutical Sciences of Ankara;1999-2001, 2003-ongoing;Pharmaceutical Science (Q4)
597;19700175785;Open Access Journal of Clinical Trials;journal;11791519;0.116;Q3;9;18;4;632;1;4;0.25;35,11;New Zealand;Dove Medical Press Ltd;2009-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Pharmacology (medical) (Q4)"
598;4700151603;Journal of Pharmacy of Istanbul University;journal;03677524;0.115;Q4;7;11;26;215;6;26;0.0;19,55;Turkey;Istanbul Universitesi Eczacilik Fakultesi;2005, 2007-2008, 2010, 2012, 2015-ongoing;"Pharmaceutical Science (Q4); Pharmacy (Q4)"
599;4800154015;S.T.P. Pharma Pratiques;journal;11571497;0.115;Q4;9;25;96;221;5;94;0.09;8,84;France;Editions de Sante;1991-2014, 2017-ongoing;Pharmaceutical Science (Q4)
600;19700180781;Strategies and Tactics in Organic Synthesis;book series;18746004;0.115;Q4;8;0;15;0;3;13;0.23;0,00;United States;Elsevier Inc.;2004-2005, 2008, 2012-ongoing;"Drug Discovery (Q4); Organic Chemistry (Q4)"
601;21100197929;Toxicological Research;journal;19768257;0.115;Q4;20;11;76;356;5;76;0.07;32,36;South Korea;Korean Association of Medical Journal Editors;2008-ongoing;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
602;19700175137;Trends in Medical Research;journal;18193587;0.115;Q3;8;5;20;279;4;20;0.2;55,80;United States;Academic Journals Inc.;2008-2016 (cancelled);"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Medicine (miscellaneous) (Q4)"
603;22358;U.S. Pharmacist;journal;01484818;0.115;Q4;7;136;444;2380;35;418;0.09;17,50;United States;Jobson Publishing LLC;1979, 1990-1996, 2007-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacy (Q4)"
604;19700200880;Botulinum Journal;journal;17547326;0.114;Q4;5;8;8;292;3;6;0.5;36,50;Switzerland;Inderscience Publishers;2009-2013, 2016-ongoing;"Biochemistry (Q4); Cellular and Molecular Neuroscience (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
605;11400153330;Recent Patents on Endocrine, Metabolic and Immune Drug Discovery;journal;18722148;0.114;Q4;20;24;43;2355;17;43;0.4;98,13;United Arab Emirates;Bentham Science Publishers;2008-ongoing;"Biochemistry (medical) (Q4); Drug Discovery (Q4); Endocrinology, Diabetes and Metabolism (Q4); Immunology and Allergy (Q4); Medicine (miscellaneous) (Q4)"
606;19430;Adverse Drug Reaction Bulletin;journal;00446394;0.113;Q4;7;6;16;267;5;16;0.1;44,50;United States;Lippincott Williams & Wilkins Ltd.;1970, 1973-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
607;20543;Pharmacometrics;journal;03008533;0.113;Q4;6;23;16;309;3;16;0.19;13,43;Japan;Japanese Society or Pharmacometrics;1973-2004, 2009-2012;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
608;19700181403;Pharmaceutical Outsourcing;journal;19453337, 19453345;0.112;Q4;5;40;121;147;2;118;0.02;3,68;United States;Russell Publishing LLC;2010-ongoing;"Health Policy (Q4); Pharmaceutical Science (Q4)"
609;19700174924;Biomedical and Pharmacology Journal;journal;09746242, 24562610;0.111;Q4;12;79;88;1261;5;88;0.06;15,96;India;Oriental Scientific Pub. Co.;2009-ongoing;Pharmacology (Q4)
610;50087;EBR - European Biopharmaceutical Review;journal;13690663;0.111;Q4;5;51;234;342;3;233;0.02;6,71;United Kingdom;Samedan Ltd.;2004-ongoing;Pharmaceutical Science (Q4)
611;25196;Revista Brasileira de Toxicologia;journal;14152983;0.111;Q4;6;6;29;163;1;28;0.0;27,17;Brazil;Sociedade Brasileira de Toxicologia;2000-2010;Toxicology (Q4)
612;20628;Circular Farmaceutica;journal;00097314;0.11;Q4;2;30;120;391;1;106;0.01;13,03;Spain;Colegio Official de Farmaceuticos de la Provincia de Barcelona;1961, 1973-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
613;19700182629;Methods in Pharmacology and Toxicology;book series;15572153;0.11;Q4;6;0;22;0;4;21;0.19;0,00;United States;Humana Press, Inc.;2008, 2012-ongoing;"Molecular Medicine (Q4); Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
614;19700175018;Psychopharmacology and Biological Narcology;journal;16068181, 20705670;0.11;Q4;2;1;11;31;1;11;0.09;31,00;Russian Federation;SRL Archive;2009-2012;"Pharmacology (Q4); Psychiatry and Mental Health (Q4)"
615;17716;Quality Assurance Journal;journal;10991786, 10878378;0.109;Q4;7;11;47;73;11;39;0.11;6,64;United States;John Wiley & Sons Inc.;1998, 2000-2007, 2009-2011;"Medicine (miscellaneous) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
616;21227;Pharmacy in Practice;journal;13581538;0.108;Q4;5;0;131;0;1;112;0.01;0,00;United Kingdom;Medicom Publishing;1995-2009;"Health Policy (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Pharmacy (Q4)"
617;21100204921;Bulletin of Pharmaceutical Sciences;journal;11100052;0.107;Q4;7;21;49;624;4;48;0.08;29,71;Egypt;Faculty of Pharmacy, Assiut University;2008-2013;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
618;22887;Chinese Journal of Antibiotics;journal;10018689;0.107;Q4;10;175;500;2211;25;499;0.05;12,63;China;Editorial Office of the Chinese Journal of Antibiotics;1983-2015;Pharmacology (Q4)
619;15600154705;EnvironmentAsia;journal;19061714;0.107;Q4;14;61;16;1150;2;16;0.13;18,85;Thailand;Thai Society of Higher Education Institutes on Environment;2009-ongoing;"Environmental Science (miscellaneous) (Q4); Toxicology (Q4)"
620;21840;Folia Pharmacologica Japonica;journal;00155691, 13478397;0.107;Q4;17;111;356;2191;25;352;0.06;19,74;Japan;Nippon Yakuri Gakkai;1961-ongoing;Pharmacology (Q4)
621;19500157008;Fooyin Journal of Health Sciences;journal;18778607;0.106;Q4;5;21;14;503;1;13;0.08;23,95;Netherlands;Elsevier BV;2009-2010;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Biomedical Engineering (Q4); Drug Discovery (Q4); Medicine (miscellaneous) (Q4)"
622;21243;Pharmacy times;trade journal;00030627;0.106;Q4;8;196;632;1009;12;557;0.02;5,15;United States;Romaine Pierson Publishers;1947-1949, 1975, 1977-1987, 2007-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacy (Q4)"
623;25197;Revista de Toxicologia;journal;16970748, 02127113;0.106;Q4;9;15;35;85;3;34;0.05;5,67;Spain;Asociacion Espanola de Toxicologia;1989-2017 (cancelled);Toxicology (Q4)
624;17700156777;Advances in Pharmacological Sciences;journal;16876342, 16876334;0.105;Q4;22;7;4;518;0;4;0.0;74,00;Egypt;Hindawi Publishing Corporation;2009-ongoing;"Molecular Medicine (Q4); Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
625;17744;Anales de la Real Academia Nacional de Medicina;journal;00340634;0.105;Q4;6;41;106;0;6;106;0.02;0,00;Spain;Real Academia Nacional de Medicina;1949-2011;"Cell Biology (Q4); Medicine (miscellaneous) (Q4); Molecular Biology (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
626;27715;Anil Aggrawal's Internet Journal of Forensic Medicine and Toxicology;journal;09728074;0.105;Q4;9;9;28;90;2;22;0.14;10,00;India;Anil Aggrawal;2000-ongoing;"Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
627;19700174886;Arzneimitteltherapie;journal;07236913;0.105;Q4;6;140;300;1195;11;123;0.09;8,54;Germany;Wissenschaftliche Verlagsgesellschaft;2008-ongoing;"Pharmacology (nursing) (Q3); Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
628;19700174922;Chinese Journal of New Drugs;journal;10033734;0.105;Q4;9;250;1019;3029;42;1019;0.04;12,12;China;Chinese Journal of New Drugs Co. Ltd.;2008-ongoing;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
629;9500153932;Ciencia y Tecnologia Pharmaceutica;journal;15753409;0.105;Q4;6;0;6;0;0;4;0.0;0,00;Spain;Alpe Editores;1996-2007;Pharmacology (Q4)
630;13000154717;Current Topics in Toxicology;journal;09728228;0.105;Q4;6;0;16;0;1;16;0.11;0,00;India;Research Trends;2007-2009, 2011-ongoing;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
631;19700174997;ONdrugDelivery;trade journal;2049145X;0.105;Q4;5;36;4;264;0;4;0.0;7,33;United Kingdom;Frederick Furness Publishing;2009-ongoing;Pharmaceutical Science (Q4)
632;19700181241;Physiology and Pharmacology;journal;24765236, 24765244;0.105;Q4;9;43;46;1357;4;46;0.09;31,56;Iran;Neuroscience Research Center;2009-ongoing;"Pharmacology (Q4); Physiology (Q4)"
633;21836;Revista Mexicana de Ciencias Farmaceuticas;journal;10273956;0.105;Q4;8;32;78;842;1;61;0.03;26,31;Mexico;Asociacion Farmaceutica Mexicana;1997-2015;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
634;145000;Signal;journal;14719967;0.105;Q4;1;0;5;0;0;4;0.0;0,00;United Kingdom;Adis International Ltd.;2005-2007;"Drug Discovery (Q4); Oncology (Q4); Pharmacology (medical) (Q4)"
635;19700174992;European Journal of Oncology Pharmacy;journal;20327072, 17833914;0.104;Q4;3;41;43;209;1;37;0.03;5,10;Belgium;Pharma Publishing and Media Europe;2008-ongoing;"Oncology (Q4); Pharmacology (Q4)"
636;19700175015;Infection and Drug Resistance;journal;11786973;0.104;Q4;27;3;6;95;0;5;0.0;31,67;New Zealand;Dove Medical Press Ltd;2009-ongoing;"Infectious Diseases (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
637;19600157763;Research in Pharmaceutical Sciences;journal;17355362, 17359414;0.104;Q4;20;14;12;408;1;12;0.08;29,14;India;Medknow Publications;2009-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
638;17700155411;Research Journal of Environmental Toxicology;journal;18193420;0.104;Q4;12;34;16;861;1;16;0.06;25,32;United States;Academic Journals Inc.;2009-2016 (cancelled);"Health, Toxicology and Mutagenesis (Q4); Pollution (Q4); Toxicology (Q4)"
639;110141;Sangyo eiseigaku zasshi = Journal of occupational health;journal;13410725;0.104;Q4;11;26;41;15;9;41;0.24;0,58;Japan;Nihon Sangyo Eisei Gakkai;1995-ongoing;"Medicine (miscellaneous) (Q4); Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
640;86688;Acta Toxicologica;journal;17316383;0.103;Q4;7;0;21;0;7;19;0.0;0,00;Poland;Instytut Medycyny Pracy im. Jerzego Nofera/Nofer Institute of Occupational Medicine;2003-2007;Toxicology (Q4)
641;19700174892;Chinese Journal of Cancer Biotherapy;journal;1007385X;0.103;Q4;3;133;260;3149;8;256;0.03;23,68;China;Chinese Journal of Cancer Biotheraphy;2008-ongoing;"Cancer Research (Q4); Molecular Medicine (Q4); Pharmacology (Q4)"
642;21100829255;Chinese Journal of Pharmaceutical Biotechnology;journal;10058915;0.103;Q4;4;121;310;1818;12;310;0.04;15,02;China;China Pharmaceutical University;2007-ongoing;"Applied Microbiology and Biotechnology (Q4); Pharmaceutical Science (Q4)"
643;19700174889;Drug Target Insights;journal;11773928;0.103;Q4;10;0;15;0;3;15;0.2;0,00;New Zealand;Libertas Academica;2008-ongoing;"Clinical Biochemistry (Q4); Medicine (miscellaneous) (Q4); Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
644;19700175049;Internet Journal of Toxicology;journal;15593916;0.103;Q4;5;21;17;540;1;17;0.06;25,71;United States;Internet Scientific Publications;2009-2011, 2013, 2015;Toxicology (Q4)
645;23009;Journal of Clinical Research;journal;13695207;0.103;Q4;11;0;5;0;0;5;0.0;0,00;United Kingdom;Brookwood Medical Publications Ltd;1998-2009;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
646;15323;Journal of Jilin University Medicine Edition;journal;1671587X;0.103;Q4;5;224;759;2585;23;759;0.02;11,54;China;Jilin University;2005-ongoing;Pharmacology (Q4)
647;13637;Manufacturing Chemist;journal;02624230;0.103;Q4;6;109;222;156;2;203;0.01;1,43;United Kingdom;Polygon Media Ltd.;1981-1984, 1986, 1989, 1996-2001, 2006-ongoing;Pharmaceutical Science (Q4)
648;12100156730;Pharmaceutische Weekblad Wetenschappelijk Platform;journal;18738982;0.103;Q4;2;0;11;0;1;10;0.1;0,00;Netherlands;Kon. Ned. Mij. ter Bevordering der Pharmacie (KNMP);2008, 2013-2015;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
649;5200152604;Pharma Times;journal;00316849;0.103;Q4;10;90;225;602;18;158;0.14;6,69;India;Indian Pharmaceutical Association;2006-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
650;19700175031;Research Journal of Pharmacology;journal;18159362, 19936109;0.103;Q4;7;18;24;385;3;24;0.13;21,39;Pakistan;Medwell Online;2008-2016 (cancelled);"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
651;19700181314;2009 IEEE 3rd International Conference on Nano/Molecular Medicine and Engineering, NANOMED 2009;conference and proceedings;00002009;0.102;-;4;0;71;0;3;70;0.04;0,00;United States;;2009;"Molecular Medicine; Pharmacology"
652;19700182785;Ethiopian Pharmaceutical Journal;journal;10295933;0.102;Q4;3;0;15;0;1;15;0.07;0,00;Ethiopia;Ethiopian Pharmaceutical Association;2009;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
653;21823;Farmatsija;journal;04280296;0.102;Q4;5;7;28;237;1;28;0.05;33,86;Bulgaria;Meditsinski Universitet - Sofia;1945, 1954-1955, 1987-1991, 1997-ongoing;"Pharmaceutical Science (Q4); Pharmacology (medical) (Q4); Pharmacy (Q4)"
654;19700189400;Pharmaceutical Sciences;journal;23832886, 1735403X;0.102;Q4;12;21;42;558;2;42;0.05;26,57;Iran;Tabriz University of Medical Sciences;2009-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
655;5000158117;Profiles of Drug Substances, Excipients and Related Methodology;book series;18715125;0.102;Q4;15;9;15;618;2;3;0.0;68,67;United States;Elsevier Inc.;2001-2003, 2005, 2007-ongoing;"Medicine (miscellaneous) (Q4); Molecular Medicine (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
656;89630;Psychopharmakotherapie, Supplement;journal;09465146;0.102;Q4;2;0;17;0;0;11;0.0;0,00;Germany;Wissenschaftliche Verlagsgesellschaft;1997-1999, 2004-2005, 2007-2008;"Pharmacology (Q4); Psychiatry and Mental Health (Q4)"
657;88685;Annual Report of Shionogi Research Laboratory;journal;05598680;0.101;Q4;2;0;27;0;0;24;0.0;0,00;Japan;Research Laboratory of Shionogi and Co.;1972-1974, 1987-2009, 2015;Pharmacology (Q4)
658;19700175119;Asian Journal of Pharmaceutical Sciences;journal;18180876;0.101;Q4;27;28;40;836;1;40;0.03;29,86;China;Shenyang Pharmaceutical University;2009-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
659;19700173109;Contract Pharma;trade journal;15443469;0.101;Q4;3;146;103;119;3;86;0.03;0,82;United States;Contract Pharma;2009-ongoing;"Industrial Relations (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
660;4700152278;Drugs in Context;journal;17404398, 17451981;0.101;Q4;12;0;31;0;0;26;0.0;0,00;United Kingdom;BioExcel Publishing Ltd;2006-2008, 2012-ongoing;"Molecular Medicine (Q4); Pharmacology (Q4)"
661;21238;Drug Topics;journal;00126616;0.101;Q4;7;218;796;36;7;590;0.01;0,17;United States;Advanstar Communications Inc.;1991, 1997-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
662;21334;EPC - European Pharmaceutical Contractor;journal;1364369X;0.101;Q4;3;70;206;235;2;201;0.02;3,36;United Kingdom;Samedan Ltd.;2002-ongoing;Pharmaceutical Science (Q4)
663;5200152843;Farmaceutico Hospitales;journal;02144697;0.101;Q4;3;14;74;66;1;58;0.05;4,71;Spain;Ediciones Mayo;2006-2009;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
664;15680;Giornale di Neuropsicofarmacologia;journal;03919048;0.101;Q4;1;0;30;0;1;25;0.06;0,00;Italy;C I C Edizioni International srl;1996-2008;"Neurology (clinical) (Q4); Neuropsychology and Physiological Psychology (Q4); Neuroscience (miscellaneous) (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
665;21932;Hindustan Antibiotics Bulletin;journal;00181935;0.101;Q4;8;0;14;0;0;14;0.0;0,00;India;Hindustan Antibiotics Ltd.;1960-1961, 1965-2000, 2002-2003, 2005, 2007;Pharmacology (Q4)
666;19700175056;Jordan Journal of Pharmaceutical Sciences;journal;19957157;0.101;Q4;8;17;16;349;0;16;0.0;20,53;Jordan;University of Jordan;2009-ongoing;Pharmaceutical Science (Q4)
667;94365;Journal of Phytomedicine and Therapeutics;journal;11181028;0.101;Q4;5;0;20;0;1;20;0.0;0,00;Nigeria;National Institute for Pharmaceutical Research and Development;2000-2003, 2007, 2009;Pharmacology (Q4)
668;86349;Oral Therapeutics and Pharmacology;journal;02881012;0.101;Q4;5;11;38;204;6;37;0.18;18,55;Japan;Shika Yakubutsu Ryoho Kenkyukai;1984-ongoing;"Dentistry (miscellaneous) (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
669;19700174966;Pharmakeftiki;journal;11054999;0.101;Q4;2;2;30;219;0;28;0.0;109,50;Greece;Papathanasopoulos;2008-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
670;72755;Phytomedica;journal;09723293;0.101;Q4;4;0;29;0;0;29;0.0;0,00;India;Scientific Publishers;1999-2006;"Complementary and Alternative Medicine (Q4); Pharmacology (Q4)"
671;17783;Research Communications in Molecular Pathology and Pharmacology;journal;10780297;0.101;Q4;37;0;17;0;0;17;0.0;0,00;United States;PJD Publications Ltd.;1994-2007, 2009;"Medicine (miscellaneous) (Q4); Molecular Medicine (Q4); Pharmacology (Q4)"
672;4100151606;Actualites Pharmaceutiques Hospitalieres;journal;17697344;0.1;Q4;2;41;75;144;0;62;0.0;3,51;Netherlands;Elsevier BV;2005-2012;Pharmaceutical Science (Q4)
673;19700182251;Air and Waste Management Association - Harmonizing Greenhouse Gas Assessment and Reporting Processes 2009;conference and proceedings;00002009;0.1;-;0;0;44;0;0;42;0.0;0,00;United States;;2009;"Ecology; Pollution; Toxicology; Waste Management and Disposal"
674;9800153152;Archivos Venezolanos de Farmacologia y Terapeutica;journal;07980264;0.1;Q4;4;19;63;368;1;58;0.0;19,37;Venezuela;Tribuna Medica Venezolana;2007-2013, 2015-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
675;19700171709;Arhiv za Farmaciju;journal;00041963, 22178767;0.1;Q4;3;35;36;828;1;36;0.03;23,66;Serbia;Farmaceutsko Drustvo Srbije;1954-1955, 2009-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
676;19700175121;Azerbaijan Pharmaceutical and Pharmacotherapy Journal;journal;19941951;0.1;Q4;2;18;36;202;0;36;0.0;11,22;Azerbaijan;Azarbaucan Tibb Universiteti;2009-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
677;5100154302;European Biotechnology Science and Industry News;journal;16188276;0.1;Q4;2;41;144;33;1;124;0.0;0,80;Germany;Biocom AG;2006-2013;"Biotechnology (Q4); Drug Discovery (Q4)"
678;19700174996;European Life Science Journal;trade journal;20001444;0.1;Q4;1;35;86;3;1;85;0.01;0,09;Thailand;The Psychiatric Association of Thailand;2009-2011;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
679;21798;Farmaceutski Glasnik;journal;00148202;0.1;Q4;5;69;169;421;4;143;0.03;6,10;Croatia;Hrvatsko Farmaceutsko Drustvo/Croatian Pharmaceutical Society;1950-1951, 1962, 1990-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
680;21867;Geneesmiddelenbulletin;journal;03044629;0.1;Q4;6;48;164;130;1;47;0.03;2,71;Netherlands;Stichting Geneesmiddelenbulletin;1973-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
681;78698;Japanese Journal of Clinical Pharmacology and Therapeutics;journal;03881601;0.1;Q4;7;77;249;657;2;242;0.01;8,53;Japan;Nihon Rinsho Yakuri Gakkai/Japanese Society of Clinical Pharmacology and Therapeutics;1987-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
682;19700169211;Life Science Clusters;trade journal;17528119;0.1;Q4;0;11;60;0;0;55;0.0;0,00;United Kingdom;Avakado Limited;2009-2010;"Biotechnology (Q4); Industrial Relations (Q4); Management of Technology and Innovation (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
683;19700175602;Next Generation Pharmaceutical;trade journal;-;0.1;Q4;1;81;109;0;1;75;0.01;0,00;United Kingdom;GDS International;2009-2011;"Drug Discovery (Q4); Marketing (Q4); Organizational Behavior and Human Resource Management (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4); Strategy and Management (Q4)"
684;21077;Pharmaca;journal;00316857;0.1;Q4;4;11;49;354;0;41;0.0;32,18;Croatia;Association of Croatian Health Organizations;1989-2011;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
685;19700181430;Pharmaceutical Manufacturing and Packing Sourcer;trade journal;14631245;0.1;Q4;3;67;71;246;1;71;0.01;3,67;United Kingdom;Samedan Pharmaceutical Publishers Ltd.;2009-ongoing;"Pharmaceutical Science (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
686;5000158120;Pharmacy News;journal;1448207X;0.1;Q4;1;121;700;0;1;273;0.01;0,00;Spain;Reed Business Information Ltd;2006-2011;"Pharmaceutical Science (Q4); Pharmacology (nursing) (Q4)"
687;5800207507;Side Effects of Drugs Annual;book series;03786080;0.1;Q4;5;52;155;4867;5;102;0.06;93,60;Netherlands;Elsevier BV;1977-1995, 1997-2005, 2007-ongoing;"Drug Guides (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
688;16800154712;Sp2;trade journal;1476184X;0.1;Q4;1;74;64;64;1;58;0.02;0,86;United Kingdom;Manor Creative;2009-2014;"Drug Discovery (Q4); Molecular Medicine (Q4)"
689;21100239606;Therapeutic Innovation and Regulatory Science;journal;21684790;0.1;Q4;12;63;129;1080;0;128;0.0;17,14;United States;SAGE Publications Inc.;1970, 1972, 1974-2006, 2008-2011, 2013-ongoing;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4); Public Health, Environmental and Occupational Health (Q4)"
690;19800188037;2010 IEEE International Conference on Nano/Molecular Medicine and Engineering, IEEE NANOMED 2010;conference and proceedings;00002010;;-;4;54;0;774;0;0;0.0;14,33;United States;;2010;"Molecular Medicine; Pharmacology"
691;21100229846;2010 International Symposium on Waterborne Pathogens;conference and proceedings;00002010;;-;1;33;0;55;0;0;0.0;1,67;United States;;2010;"Health, Toxicology and Mutagenesis; Toxicology"
692;19700177127;ACS Medicinal Chemistry Letters;journal;19485875;;-;52;109;0;2718;0;0;0.0;24,94;United States;American Chemical Society;2010-ongoing;"Biochemistry; Drug Discovery; Organic Chemistry"
693;19700174978;American Journal of Pharmacy Benefits;journal;19454481;;-;11;56;0;911;0;0;0.0;16,27;United States;Managed Care & Healthcare Communications LLC;2010-ongoing;"Business and International Management; Decision Sciences (miscellaneous); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
694;21100469670;Antibiotics;journal;20796382;;-;20;1;0;140;0;0;0.0;140,00;Switzerland;Multidisciplinary Digital Publishing Institute (MDPI);2014-ongoing;"Biochemistry; Infectious Diseases; Microbiology; Microbiology (medical); Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
695;21100201952;Arsenic in Geosphere and Human Diseases, As 2010 - 3rd International Congress: Arsenic in the Environment;conference and proceedings;00002010;;-;4;234;0;1622;0;0;0.0;6,93;United States;;2010;"Health, Toxicology and Mutagenesis; Toxicology"
696;21100229867;AWWA 2010 Inorganic Contaminants Workshop;conference and proceedings;00002010;;-;1;29;0;49;0;0;0.0;1,69;United States;;2010;"Health, Toxicology and Mutagenesis; Toxicology"
697;19700173005;Cancer Nanotechnology;journal;18686958, 18686966;;-;19;9;0;296;0;0;0.0;32,89;United States;Springer Science + Business Media;2010-ongoing;"Biomedical Engineering; Oncology; Pharmaceutical Science; Physical and Theoretical Chemistry"
698;19700174609;Clinical Medicine Insights: Therapeutics;journal;1179559X;;-;6;39;0;2365;0;0;0.0;60,64;New Zealand;Libertas Academica;2010-ongoing;"Medicine (miscellaneous); Pharmaceutical Science; Pharmacology"
699;21100212330;Drug discoveries & therapeutics;journal;1881784X, 18817831;;-;19;52;0;0;0;0;0.0;0,00;Japan;International Advancement Center for Medicine & Health Research Co., Ltd. (IACMHR Co., Ltd.);2012-ongoing;"Medicine (miscellaneous); Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
700;19700201201;EPMA Journal;journal;18785077, 18785085;;-;26;57;0;4343;0;0;0.0;76,19;United Kingdom;BioMed Central;2010-ongoing;"Biochemistry (medical); Drug Discovery; Health Policy"
701;21100195303;Eurasian Journal of Analytical Chemistry;journal;13063057;;-;8;1;0;31;0;0;0.0;31,00;Turkey;Moment Publications;2011-ongoing;"Analytical Chemistry; Electrochemistry; Pharmaceutical Science; Spectroscopy"
702;19700174811;European Journal of Parenteral and Pharmaceutical Sciences;journal;17406277;;-;5;19;0;319;0;0;0.0;16,79;United Kingdom;Euromed Communications Ltd;2010-2015;"Pharmaceutical Science; Pharmacy"
703;19700176055;F1000 Biology Reports;journal;17404118;;-;27;88;0;2780;0;0;0.0;31,59;United Kingdom;Faculty of 1000 Ltd;2010-2013;"Biochemistry, Genetics and Molecular Biology (miscellaneous); Immunology and Microbiology (miscellaneous) ; Neuroscience (miscellaneous); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
704;19700174923;Farmaceutyczny Przeglad Naukowy;journal;14255073;;-;3;85;0;2153;0;0;0.0;25,33;Poland;Medical University of Silesia;2010-2011;Pharmaceutical Science
705;21100214102;Frontiers in Pharmacology;journal;16639812;;-;62;41;0;1928;0;0;0.0;47,02;Switzerland;Frontiers Media S.A.;2010-ongoing;"Pharmacology; Pharmacology (medical)"
706;19700181240;Global Journal of Pharmacology;journal;19920075;;-;13;24;0;559;0;0;0.0;23,29;Pakistan;International Digital Organization for Scientific Information (IDOSI);2010-2014 (cancelled);Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
707;19700188318;International Journal of Advances in Pharmaceutical Sciences;journal;09761055;;-;10;51;0;1401;0;0;0.0;27,47;United States;Advanced Research Journals;2010-2011 (cancelled);"Pharmaceutical Science; Physical and Theoretical Chemistry"
708;21100421502;International Journal of Biomedical Nanoscience and Nanotechnology;journal;17560802, 17560799;;-;7;14;0;894;0;0;0.0;63,86;United Kingdom;Inderscience Publishers;2010-2012;"Biomedical Engineering; Medicine (miscellaneous); Pharmaceutical Science"
709;19700200860;International Journal of Current Pharmaceutical Review and Research;journal;0976822X;;-;9;13;0;341;0;0;0.0;26,23;India;Publishers, In-IJCPR;2010-2016 (cancelled);Pharmaceutical Science
710;19700175758;International Journal of Drug Development and Research;journal;09759344;;-;17;121;0;2516;0;0;0.0;20,79;India;International Journal of Drug Development and Research;2010-2015 (cancelled);Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
711;19700200861;International Journal of Pharmaceutical Sciences;journal;09754725;;-;8;79;0;1627;0;0;0.0;20,59;India;R R College of Pharmacy;2010, 2012-2013;"Drug Discovery; Pharmaceutical Science"
712;19700188319;International Journal of Pharmaceutical Sciences Review and Research;journal;0976044X;;-;24;307;0;7821;0;0;0.0;25,48;India;Global Research Online;2010-2016 (cancelled);Pharmaceutical Science
713;19700188355;International Journal of Phytomedicine;journal;09750185;;-;15;59;0;1635;0;0;0.0;27,71;United States;Advanced Research Journals;2010-2016 (cancelled);"Complementary and Alternative Medicine; Drug Discovery"
714;19700175778;International Journal of Research in Pharmaceutical Sciences;journal;09757538;;-;15;72;0;1500;0;0;0.0;20,83;India;JK Welfare & Pharmascope Foundation;2010-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
715;19700174628;Iranian Journal of Basic Medical Sciences;journal;20083874, 20083866;;-;27;33;0;944;0;0;0.0;28,61;Iran;University of Medical Sciences;2010-ongoing;"Biochemistry; Biophysics; Clinical Biochemistry; Drug Discovery; Immunology and Microbiology (miscellaneous) "
716;19700183012;Iranian Journal of Pharmaceutical Sciences;journal;17352444;;-;9;34;0;790;0;0;0.0;23,24;Iran;Shiraz University of Medical Sciences;2010-ongoing;"Bioengineering; Pharmaceutical Science"
717;19700172219;ISB 2010 Proceedings - International Symposium on Biocomputing;conference and proceedings;00002010;;-;4;50;0;1000;0;0;0.0;20,00;United States;;2010;"Biochemistry, Genetics and Molecular Biology (miscellaneous); Computational Theory and Mathematics; Pharmaceutical Science; Software"
718;19700201137;Journal of Advanced Pharmaceutical Technology and Research;journal;01105558, 09762094;;-;26;60;0;1214;0;0;0.0;20,23;India;Medknow Publications and Media Pvt. Ltd;2010-ongoing;Pharmaceutical Science
719;19700201141;Journal of Ayurveda and Integrative Medicine;journal;09759476, 09762809;;-;19;64;0;1049;0;0;0.0;16,39;Netherlands;Elsevier BV;2010-ongoing;"Complementary and Alternative Medicine; Drug Discovery"
720;19700188309;Journal of Bioanalysis and Biomedicine;journal;1948593X;;-;9;23;0;518;0;0;0.0;22,52;India;OMICS Publishing Group;2010-2014 (cancelled);Pharmaceutical Science
721;19700201516;Journal of Chemical and Pharmaceutical Sciences;journal;09742115;;-;11;69;0;1087;0;0;0.0;15,75;India;SPB Pharma Society;2010-2016 (cancelled);"Biochemistry, Genetics and Molecular Biology (miscellaneous); Pharmaceutical Science; Pharmacology"
722;19700188356;Journal of Excipients and Food Chemicals;journal;21502668;;-;13;16;0;697;0;0;0.0;43,56;United States;IPEC-Americas;2010-ongoing;"Food Science; Pharmaceutical Science"
723;21100781436;Journal of Experimental Pharmacology;journal;11791454;;-;7;1;0;49;0;0;0.0;49,00;New Zealand;Dove Medical Press Ltd.;2010, 2013-ongoing;"Molecular Medicine; Pharmacology; Pharmacology (medical)"
724;19700200708;Journal of Global Pharma Technology;journal;09758542;;-;10;135;0;2618;0;0;0.0;19,39;India;Journal of Global Pharma Technology;2010-ongoing;Pharmaceutical Science
725;19700174645;Journal of International Pharmaceutical Research;journal;16740440;;-;8;51;0;968;0;0;0.0;18,98;India;Journal of International Pharmaceutical Research;2010-ongoing;"Pharmaceutical Science; Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
726;21100241608;Journal of Nanomedicine and Nanotechnology;journal;21577439;;-;19;3;0;70;0;0;0.0;23,33;India;OMICS Publishing Group;2010-2014 (cancelled);"Bioengineering; Biomedical Engineering; Medicine (miscellaneous); Pharmaceutical Science"
727;19700201423;Journal of Pharmaceutical Health Services Research;journal;17598885, 17598893;;-;12;29;0;763;0;0;0.0;26,31;United Kingdom;John Wiley and Sons Ltd;2010-ongoing;"Economics, Econometrics and Finance (miscellaneous); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
728;21100216519;Journal of Pharmaceutical Negative Results;journal;09769234, 22297723;;-;5;16;0;219;0;0;0.0;13,69;India;Medknow Publications and Media Pvt. Ltd;2010-ongoing;"Drug Discovery; Pharmaceutical Science; Pharmacology"
729;21100325142;Journal of Pharmaceutical Policy and Practice;journal;20523211;;-;12;15;0;260;0;0;0.0;17,33;United Kingdom;BioMed Central;2013-ongoing;"Health Policy; Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
730;19700175120;Journal of Pharmaceutical Research and Health Care;journal;09753648;;-;7;48;0;767;0;0;0.0;15,98;India;Medknow Publications;2010-2011;Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
731;19700175858;Journal of Pharmacognosy and Phytotherapy;journal;21412502;;-;18;17;0;353;0;0;0.0;20,76;Nigeria;Academic Journals;2010-2016 (cancelled);Drug Discovery
732;21100209502;Journal of Pharmacology and Pharmacotherapeutics;journal;0976500X, 09765018;;-;26;15;0;346;0;0;0.0;23,07;India;Medknow Publications and Media Pvt. Ltd;2010-ongoing;"Pharmacology; Pharmacology (medical)"
733;19700174632;Journal of Receptor, Ligand and Channel Research;journal;1178699X;;-;7;5;0;399;0;0;0.0;79,80;United Kingdom;Dove Medical Press Ltd;2010-ongoing;"Biochemistry; Biophysics; Cell Biology; Pharmacology"
734;19700175023;Journal of Toxicology;journal;16878205, 16878191;;-;26;9;0;360;0;0;0.0;40,00;Egypt;Hindawi Publishing Corporation;2010-ongoing;"Pharmacology; Toxicology"
735;21100244805;Journal of Vaccines and Vaccination;journal;21577560;;-;9;12;0;491;0;0;0.0;40,92;India;OMICS Publishing Group;2010-2014 (cancelled);"Drug Discovery; Immunology; Immunology and Allergy; Virology"
736;19700177128;Journal of Young Pharmacists;journal;09751505, 09751483;;-;22;83;0;1417;0;0;0.0;17,07;India;EManuscript Services;2010-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
737;21100874234;Latin American Journal of Pharmacy;journal;23623853, 03262383;;-;17;181;381;4613;137;381;0.37;25,49;Argentina;Colegio de Farmaceuticos de la Provincia de Buenos Aires;2007-ongoing;"Drug Discovery; Pharmaceutical Science"
738;21100242405;Marmara Pharmaceutical Journal;journal;13090801;;-;10;22;0;735;0;0;0.0;33,41;Turkey;Marmara University;2010-ongoing;"Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
739;19700194010;MedChemComm;journal;20402503, 20402511;;-;44;48;0;1878;0;0;0.0;39,13;United Kingdom;Royal Society of Chemistry;2010-ongoing;"Biochemistry; Pharmaceutical Science"
740;19800188074;Medicinal Plants - International Journal of Phytomedicines and Related Industries;journal;09754261, 09756892;;-;8;39;0;957;0;0;0.0;24,54;Netherlands;IOS Press;2010-ongoing;"Drug Discovery; Organic Chemistry; Plant Science"
741;19700201410;Milestones in Drug Therapy;book series;22966056;;-;4;41;0;3385;0;0;0.0;82,56;United States;Springer Science + Business Media;2010-ongoing;"Drug Discovery; Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
742;19700180522;Molecular and Cellular Toxicology;journal;1738642X;;-;18;54;0;1499;0;0;0.0;27,76;Germany;Springer Verlag;2010-ongoing;"Health, Toxicology and Mutagenesis; Pathology and Forensic Medicine; Pharmacology, Toxicology and Pharmaceutics (miscellaneous); Public Health, Environmental and Occupational Health; Toxicology"
743;19700178100;Nanotechnology, Science and Applications;journal;11778903;;-;23;17;0;1083;0;0;0.0;63,71;New Zealand;Dove Medical Press Ltd.;2010-2012, 2014-ongoing;"Bioengineering; Biomedical Engineering; Nanoscience and Nanotechnology; Pharmaceutical Science"
744;19700188437;Open Access Journal of Medicinal and Aromatic Plants;journal;09747877;;-;6;8;0;176;0;0;0.0;22,00;India;Medicinal and Aromatic Plants Association of India;2010-ongoing;"Complementary and Alternative Medicine; Drug Discovery"
745;21100205919;Open Drug Discovery Journal;journal;18773818;;-;8;26;0;1967;0;0;0.0;75,65;United Arab Emirates;Bentham Science Publishers;2010, 2014;Drug Discovery
746;19700201404;Open Drug Safety Journal;journal;18768180;;-;3;1;0;29;0;0;0.0;29,00;Netherlands;Bentham Science Publishers B.V.;2010-2011;Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
747;19700174975;Pharmaceutical Formulation and Quality;trade journal;15312135;;-;1;49;0;79;0;0;0.0;1,61;Germany;Wiley - VCH Verlag GmbH & CO. KGaA;2010-2012;Pharmaceutical Science
748;19700188360;Pharmaceutics;journal;19994923;;-;32;28;0;962;0;0;0.0;34,36;Switzerland;Multidisciplinary Digital Publishing Institute (MDPI);2010-ongoing;Pharmaceutical Science
749;19900191846;PharmacoEconomics - German Research Articles;journal;1868677X, 16123727;;-;3;9;0;239;0;0;0.0;26,56;New Zealand;Adis Press;2010-2012;"Economics, Econometrics and Finance (miscellaneous); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
750;19700174941;Pharmacognosy Research;journal;09748490, 09764836;;-;25;79;0;1758;0;0;0.0;22,25;India;Medknow Publications;2010-ongoing;"Drug Discovery; Pharmacology"
751;19700175580;PharmacoVigilance Review;journal;17526752;;-;1;23;0;66;0;0;0.0;2,87;United Kingdom;Euromed Communications Ltd;2010-ongoing;"Health Policy; Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
752;21100431352;Proceedings of ISMA 2010 - International Conference on Noise and Vibration Engineering, including USD 2010;conference and proceedings;00002010;;-;12;387;0;5853;0;0;0.0;15,12;Belgium;;2010;"Health, Toxicology and Mutagenesis; Toxicology"
753;19600166320;Protein & Cell;journal;16748018, 1674800X;;-;48;139;0;6373;0;0;0.0;45,85;Germany;Springer Verlag;2010-ongoing;"Biochemistry; Biotechnology; Cell Biology; Drug Discovery; Medicine (miscellaneous)"
754;19700174658;Regulatory Rapporteur;trade journal;17428955;;-;5;76;0;360;0;0;0.0;4,74;United Kingdom;The Organisation for Professionals in Regulatory Affairs;2010-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous); Pharmacy"
755;19700188422;Research Journal of Pharmaceutical, Biological and Chemical Sciences;journal;09758585;;-;24;296;0;5803;0;0;0.0;19,60;India;RJPBCS;2010-2016 (cancelled);"Biochemistry, Genetics and Molecular Biology (miscellaneous); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
756;21100201517;RSC Drug Discovery Series;book series;20413203;;-;7;12;0;1622;0;0;0.0;135,17;United Kingdom;Royal Society of Chemistry;2010, 2014-ongoing;Drug Discovery
757;19700201140;Systematic Reviews in Pharmacy;journal;09758453;;-;11;14;0;811;0;0;0.0;57,93;India;Medknow Publications and Media Pvt. Ltd;2010-ongoing;Pharmaceutical Science
758;19700200821;Therapeutic delivery;journal;20415990, 20416008;;-;37;70;0;5019;0;0;0.0;71,70;United Kingdom;Future Medicine Ltd.;2010-ongoing;Pharmaceutical Science
